Functional analysis of the extended N-terminus for the Drosophila Raf protein and initial characterization of the Arl1 gene by Ding, Jian
Graduate Theses and Dissertations Iowa State University Capstones, Theses andDissertations
2010
Functional analysis of the extended N-terminus for
the Drosophila Raf protein and initial
characterization of the Arl1 gene
Jian Ding
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/etd
Part of the Biochemistry, Biophysics, and Structural Biology Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Ding, Jian, "Functional analysis of the extended N-terminus for the Drosophila Raf protein and initial characterization of the Arl1
gene" (2010). Graduate Theses and Dissertations. 11815.
https://lib.dr.iastate.edu/etd/11815
Functional analysis of the extended N-terminus for the Drosophila Raf protein and 
initial characterization of the Arl1 gene  
 
 
by 
 
 
Jian Ding 
 
 
 
 
A dissertation submitted to the graduate faculty 
 
in partial fulfillment of the requirements for the degree of 
 
DOCTOR OF PHILOSOPHY 
 
 
 
 
 
Major:  Biochemistry  
 
Program of Study Committee: 
Linda Ambrosio, Major Professor 
Amy Andreotti 
Jack Girton 
Ted Huiatt 
Jo Anne Powell-Coffman 
 
 
 
 
 
 
 
 
Iowa State University 
 
Ames, Iowa 
 
2010 
 
Copyright © Jian Ding, 2010.  All rights reserved. 
 ii
TABLE of CONTENTS 
 
ABSTRACT                                                                                                                        iii 
CHAPTER 1. General Introduction                                                                                 1 
                Introduction                                                                                                                1 
                Literature Review                                                                                                      3 
                Literature Cited                                                                                                        11 
                Figure Legends                                                                                                         15 
                Figures                                                                                                                       16 
CHAPTER 2. Drosophila Raf’s N-terminus Contains a Novel Conserved Region 
                and Can Contribute to Torso RTK Signaling                                                      18 
                Abstract                                                                                                                      18 
                Introduction                                                                                                              19 
                Materials and Methods                                                                                              22 
                Results                                                                                                                        25 
                Discussion                                                                                                                 34 
                Acknowledgements                                                                                                   40 
                Literature Cited                                                                                                        40 
                Tables                                                                                                                        46 
                Figure Legends                                                                                                        47 
                Figures                                                                                                                      53 
                Contribution of this work                                                                                           59 
CHAPTER 3. Initial Characterization of Drosophila Arf-like1                                      60 
                Abstract                                                                                                                     60 
                Introduction                                                                                                              61 
                Materials and Methods                                                                                             63 
                Results                                                                                                                      65 
                Discussion                                                                                                                73 
                Acknowledgements                                                                                                  77 
                Literature Cited                                                                                                         77 
                Tables                                                                                                                       81 
                Figure Legends                                                                                                         87 
                Figures                                                                                                                      90 
                Contribution of this work                                                                                          97 
CHAPTER 4. General Summary                                                                                     98 
                Summary and Conclusions                                                                                       98 
                Suggestions for Future Research                                                                           103 
                Literature Cited                                                                                                        105 
APPENDIX                                                                                                                       106 
ACKNOWLEDGEMENTS                                                                                             109 
 
 
 
 
 
 iii
ABSTRACT 
 
The Raf serine/ threonine kinases play a key role(s) in receptor tyrosine kinase (RTK) 
signaling. However, the mechanisms that modulate Raf activity are complicated and remain 
elusive. Clues to Raf regulation were derived from the identification of conserved 
regions/motifs/sites. Drosophila Raf (DRaf) has an extended N-terminus. We show this N-
terminal segment contains a novel region (CRN) that is conserved in BRaf proteins of 
vertebrates. The extended N-terminus can contribute to Torso RTK signaling during 
embryogenesis in both loss and gain-of-function genetic backgrounds. Furthermore, stronger 
interactions between DRaf’s RBD (Ras Binding Domain) and the small GTPase Ras1, as 
well as Rap1, were observed in vitro when CRN and RBD sequences were linked.  Together, 
these studies suggest that the N-terminal segment may assist in the association of DRaf with 
its activators (Ras1 and Rap1) and play a positive regulatory role(s) in DRaf activation in 
vivo through CRN-mediated mechanisms. 
We also tried to characterize the roles of DRaf’s conserved CR2 domain. In our yeast 2-
hybrid screen using CR2 as the bait, a putative DRaf binding partner, small GTPase Arf-like1 
(Arl1) protein, was identified. Using genetics approaches we have made an effort to 
understand the roles of Arl1 in Drosophila. Our studies suggest that Arl1 may function in 
membrane traffic. 
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CHAPTER 1. General Introduction 
Introduction 
Numerous fundamental cellular processes including differentiation, proliferation and 
cell survival in eukaryotes dependent on the Ras-Raf-MEK signal cassette and its regulation 
of extracellular signal-regulated kinase (ERK) pathways (SCHLESSINGER 2000). Binding of 
ligands with receptor tyrosine kinases (RTK) activates RasGEFs (Guanine-nucleotide 
exchange factors), which initiates GTP loading of Ras. GTP-Ras recruits Raf protein to the 
cell surface and triggers its activation. Once activated, Raf can phosphorylate its downstream 
effectors MEK (mitogen-activated protein and extracellular signal-regulated kinase kinase), 
subsequently leading to activation of ERK that modulates the transcriptional program of 
target genes (ROBBINS et al. 1994; Figure I-1). Dysregulation of ERK pathways caused by 
activating mutations in RTKs and components of the Ras-Raf-MEK module have been 
frequently found in human cancers (BEERAM et al. 2005; SRIKALA et al., 2005). Therefore, 
study of the regulatory mechanisms of these ERK pathway complexes, which represent the 
strategic targets of anti-tumor drugs, will be very essential for development of therapeutics 
against cancer.  
Ras has been evaluated as a putative target of anti-cancer therapeutic strategies, since 
oncogenic mutations in Ras were linked to ~15% human cancers (WELLBROCK et al. 2004). 
Both the regulatory mechanisms (GTPase cycle, post-translational modification), as well as 
the biophysical nature of Ras and other small GTPases in general have been relatively well 
defined. However, the clinical results of Ras-targeting drugs, including farnesyltransferase 
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(FTase) inhibitors (FTIs) etc, appear disappointing (ROWINSKY et al. 1999; BEERAM et al. 
2005; SRIKALA et al. 2005).  
As a major effector of Ras, the Raf serine/ threonine kinases play a key role in ERK 
signal transduction. Constitutively active forms of Raf and Ras appear to have a comparable 
potential to transform malignant cells, while expression of dominant negative mutants of Raf 
can antagonize Ras transforming activity. Furthermore, it has been discovered that BRaf is 
mutated at a high frequency in human cancers, particularly in 70-80% malignant melanomas 
(Reviewed by SRIKALA et al. 2005). These observations have led to considerable amount of 
attention paid to targeting Raf as an anticancer therapeutic strategy, thus highlighting the 
importance of Raf kinases. Therefore, understanding of the mechanisms that modulate Raf 
activity is an important issue with physiological significance.  
       Mammals have three Raf isoforms, ARaf, BRaf and CRaf, while the invertebrates 
Caenorhabditis elegans and Drosophila melanogaster have one Raf gene referred to as Lin-
45 and DRaf, respectively. All the Raf proteins share a common primary structure consisting 
of three conserved regions (CR1, CR2 and CR3, Figure I-2). Clues to regulatory events of 
Raf were derived from the identification of motifs/sites in these conserved regions. The 
catalytic portion of the kinase is located in the C-terminal conserved region 3 (CR3), while 
CR1 and CR2 represent the regulatory half of the Raf protein. Although an auto-inhibitory 
role had been previously assigned to residues compromising CR1 and CR2, the N-terminal 
regulatory part also functions in promoting Raf activity. CR1 contains a Ras-binding domain 
(RBD) and a cysteine-rich domain (CRD), and is required for recruitment of Raf to the 
plasma membrane. The Ser/Thr-rich region CR2 has a 14-3-3 binding site, but its functional 
role is less well defined (WELLBROCK et al. 2004). In addition to CR1, CR2 and CR3, BRaf 
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and DRaf contain an extended N-terminal segment followed by CR1. However, little 
attention was given to this region thus far.   
Research in our laboratory has focused on understanding the regulatory mechanisms of 
the DRaf protein in the model system Drosophila. Particularly, our goal is to characterize the 
roles of the extended N-terminal segment and CR2 region in DRaf signaling. We have found 
that the N-terminus of DRaf contains a novel region that is conserved in BRaf proteins of 
vertebrates. It may assist in Ras-DRaf interaction and can play a positive role(s) in Torso 
RTK signal transduction during Drosophila embryogenesis. We also discovered a putative 
DRaf binding partner, small GTPase Arf-like1 (Arl1) protein, which interacts with CR2 
region. Using genetics approaches we have made an effort to understand the functional roles 
of Arl1 in Drosophila. 
   
Literature Review 
Activation of Raf by Ras: Cytosolic Raf proteins exist as an “inactive” complex with 
other binding partners including 14-3-3 and heat shock protein (Hsp90). Raf has two specific 
serine residues that act in 14-3-3 binding and lie within the CR2 (Ser259, refer to CRaf) and 
CR3 (Ser621, refer to CRaf) domains, respectively. Association of either site with 14-3-3 
requires phosphorylation of the corresponding serine residues. Formation of the inactive 
complex via the interaction between 14-3-3 and both of these phospho-Ser residues may 
maintain the Raf molecule in a “closed” conformation and mask its catalytic region, since a 
Ser259 to Ala mutation that may prevent the CR2 from interacting with 14-3-3 appears to 
facilitate CRaf activation (CLARK et al. 1997; KUBICEK et al. 2002).  
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Activation of Raf is initiated by its translocation to membrane, where Raf can form a 
complex with different binding partners to elicit its full activation. The small GTPase Ras 
plays a crucial role(s) in regulation of Raf’s membrane localization and is evaluated as a 
major regulator of Raf, although it was reported that interaction between a basic motif in 
CRaf’s kinase region and phosphatidic acid (PA) can recruit Raf to the membrane in a Ras-
independent way (RIZZO et al. 2000; KRAFT et al. 2008). Association with Ras, not only 
translocates Raf to the membrane, but may disrupt 14-3-3 binding to CR2, leaving the 
phospho-Ser259 residue more accessible to dephosporylation by protein phosphatase 2A 
(PP2A) or other phosphatases (KUBICEK et al. 2002). However, the molecular mechanisms 
of Ras-Raf coupling is complicated and not completely defined.  
       Cellular Ras exists in two guanine nucleotide-bound states, GTP-Ras and GDP-Ras, with 
different molecular conformations in its switch 1 and switch 2 regions. Raf’s RBD can 
directly interact with GTP-Ras and is thought to be the core element for Ras-binding 
(NASSAR et al. 1995). Arg89 (refer to CRaf) in RBD is essential for its association with Ras 
and substitution of Arg 89 to Leu abolishes this interaction (FABIAN et al. 1994; LI et al. 
1998). In addition, CRD functions in Ras-Raf coupling, as well, through its contact with the 
lipid moiety of Ras, which is independent of GTP status of Ras. It seems the hydrophobic 
patch within CRD is required for Ras binding, since mutation of the hydrophobic surface 
impairs the interaction (WILLIAMS et al. 2000; THAPAR et al. 2004). Recently, it was found 
that BRaf’s extended N-terminus facilitated BRaf-HRas interaction in vitro, and deletion of 
the N-terminal segment reduced BRaf!s binding affinity with HRas (FISCHER et al. 2007. 
However, the identities of residues/sites in this process were not characterized.  
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Phosphorylation of Raf: Phosphorylation/dephosphorylation of Raf plays crucial roles 
in Raf regulation. Identification of conserved phosphorylation sites/motifs has provided very 
important clues in understanding Raf’s regulatory mechanisms. 
       Phosphorylation of Ser43, Ser259 and Ser233 (refer to CRaf with Ser43 and Ser233 
specific for CRaf) exhibits negative effects on Raf activation. Phosphorylation of Ser43 both 
in vivo and in vitro can reduce the apparent Ras binding affinity and appears to sterically 
prevent the interaction of CR1 with Ras (WU et al. 1993). In CR2 region, phosphorylated 
Ser259 mediates the interaction with 14-3-3 (CLARK et al. 1997). It was reported that 
phosphorylation of Ser233 provides an additional binding site for 14-3-3 (DUMAZ and 
MARAIS 2003). Therefore, phosphorylated Ser 259 and Ser233 may contribute together to 
maintain the Raf molecule in an inactive conformation.  These three serine residues (Ser43, 
Ser259 and Ser233) seem to be phosophorylated by protein kinase A (PKA) when the 
cellular cAMP level is elevated (DUMAZ et al. 2002). It was also found that Ser259 can be 
phosphotylated by AKT (also known as protein kinase B, PKB) and serum glucocorticoid-
inducible kinase (SGK) (ZIMMERMANN and MOELLING 1999; BEERAM et al. 2005) 
The C-terminal phosphorylated Ser621 (Refer to CRaf) is another 14-3-3 binding site 
and seems to play dual roles, both negatively and positively, in Raf activation. 14-3-3 
associates with both phospho-Ser259 and Ser621, and helps to maintain the inactive Raf 
complex. However, when its binding to Ser259 is disrupted, the interaction with phospho-
Ser621 seems essential to attain full activation of Raf, since mutation at Ser621 abolishes 
Raf’s activity in cultured Cos-7 cells (YIP-SCHNEIDER et al. 2000). At the present time, it is 
still controversial whether phosphorylation of Ser621 is regulated during Raf activation.   
 6
The N-region (Negatively charged) preceding the catalytic kinase domain in CRaf 
contains two additional regulatory sites Ser388 and Tyr341. Phosphorylation of these two 
residues seems to relieve the inhibitory effects of the N-terminal regulatory portion of the 
protein on its catalytic domain and is required to achieve full activation of the kinases. 
Mutations at either site block CRaf activation, and maximal activity is not obtained unless 
both sites are phosphorylated (MASON et al. 1999). Phosphorylation of Ser338 and Tyr341 in 
CRaf is likely mediated by PAK and Src family kinases, respectively (KING et al. 1998; 
TILBROOK et al. 2001).  
A few of these phosphorylation sites mentioned above are isoform specific.  The two 
conserved residues (Thr491, Ser494, refer to CRaf) residing in the active segment within the 
kinase domain are probably common to all Raf members (DOUZIECH et al. 2006). 
Phosphorylation of these two sites seems essential for activity of Raf family members with 
their mutations abolishing Raf activation (CHONG et al. 2001). However, the identity of those 
kinases, which mediate this phosphorylation, remains unknown. 
Recently, a novel phosphorylation site (Tyr510) in DRaf was identified. This Tyr 
residue is conserved in all Raf proteins. Phosphorylation of this Tyr510 by Src68B kinase 
appears to relieve autoinhibition of full-length DRaf in Drosophila (XIA et al. 2008). This 
regulatory mechanism may be shared by other Raf proteins, including ARaf, BRaf and CRaf.     
Regulation by scaffold proteins and molecular adaptors: Raf’s activity is also 
modulated through formation of functional complexes with scaffolding adaptors, including 
the kinase suppressor of Ras (KSR) and connector enhancer of KSR (CNK).  
KSR contains a C-terminal kinase-like domain, which interacts with MEK. However, 
this domain, in which the key sites essential for kinase function are substituted with other 
 7
residues. appears to be devoid of catalytic kinase activity. In stead, it has been widely depicted 
that KSR acts as a scaffold protein rather than kinase, and coordinates the assembly of Raf-
MEK-MAPK complexes (ROY et al. 2002; ROY and THERRIEN 2002; ROIGNANT et al. 2006; 
RAJAKULENDRAN et al. 2008). Recently, it was found that overexpression of KSR without 
co-overexpression of other scaffolding partners in Drosophila S2 cells could independently 
trigger DRaf activation, probably by participating in heterodimmerization with DRaf in a 
side-to-side manner. This suggests that beyond its “scaffolding” function, KSR may possess 
an intrinsic Raf activating potential (RAJAKULENDRAN et al. 2009).  
CNK does not contain any catalytic regions/motifs. Instead, CNK has several conserved 
domains, which provide numerous interaction sites for its binding partners, suggesting it 
functions as a scaffold protein (KOLCH 2005). Drosophila CNK plays dual roles in DRaf 
regulation, both negatively and positively, according to RTK signal status. Its C-terminal 
RIR (Raf inhibitory region) interacts with DRaf and inhibits Raf activity in quiescent S2 cells. 
However, once RTK is activated, the N-terminal SAM (sterile !-motif) and CRIC (a 
conserved region in CNK) regions mediate Raf activation by Ras, and the inhibitory effects 
of RIR can be relieved by active Src42 (DOUZIECH et al. 2003; DOUZIECH et al. 2006). The 
RIR is not conserved in CNK proteins of mammals. Mammalian CNK can promote CRaf 
activation by simultaneously interacting with CRaf and Src, thereby facilitating the 
phosphorylation of Tyr341 in CRaf by Src (LANIGAN et al. 2003; KOLCH 2005).  
Isoform-specific regulation of Raf kinases: All the Raf members have a similar 
primary structure, share Ras GTPase as a common regulator, MEK as the common effector, 
and were thought activated by similar means. However, differences in their regulatory 
mechanisms have recently emerged.   
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It has been reported that RBDs of different Raf isoforms differentially interact with 
active Ras. BRaf and CRaf RBD's exhibit higher binding affinity with HRas than ARaf RBD 
in vitro, and consistently, in HEK 293 cells, active HRas preferentially activates CRaf as 
compared to ARaf. The isoform specific Ras binding affinity is, at least partially, due to one 
residue difference in their RBD regions, Arg59 of CRaf is replaced with Lys (Lys22) in ARaf, 
since mutation of Lys22 to Arg in ARaf can increase its affinity to HRas in vivo and in vitro  
(WEBER et al., 2000).    
Both BRaf and CRaf can interact with the small GTPase Rap, which shares nearly 
identical effector binding portions with Ras. However, association of different Raf isoforms 
with active Rap results in distinct effects in signaling. Rap can activate BRaf in a parallel 
way with Ras, but plays a negative role and functions as an antagonist of Ras in regulating 
CRaf activity.  It was found that CRD of CRaf exhibits higher binding affinity for Rap than 
that of BRaf. The strong interaction between CRaf’s CRD and Rap may exclude Ras binding, 
therefore inhibiting activation of CRaf (OHTSUKA, et al. 1996). However, it is still unclear 
why CRaf and BRaf are regulated by Rap in distinct manners. 
       Furthermore, modulation of Raf kinases’ phosphorylation status appears to be isoform-
specific, too. The Ser43 site in CRaf is not conserved in ARaf or BRaf. BRaf contains two 
specific phosphorylation sites (Ser428 and Thr439) that ARaf and CRaf do not possess. 
Phosphorylation of Ser338 in CRaf, which is critical for its activation, is responsive to 
upstream stimulation, while the corresponding Ser445 in BRaf is constitutively 
phosphorylated. In the regulatory N-region preceding the kinase domain, BRaf lacks a 
tyrosine site corresponding to Tyr301 of ARaf and Tyr341 of CRaf, instead, it has an acidic 
residue (Asp448) in the equivalent position. To obtain full activation, Tyr301 of ARaf and 
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Tyr 341 of CRaf need to be phosphorylated by Src. However, for BRaf, the corresponding 
acidic Asp448 residue mimics consititutive phosphorylation and results in a higher basal 
activity for Braf (MASON et al., 1999).  
        Endogenous Raf proteins are predominantly distributed in the cytoplasm. However, 
overexpressed Raf kinases exhibit isoform specific intracellular localization. CRaf was found 
located in mitochondria, while ARaf was colocalized with an endosomal marker (GALMICHE 
et al. 2008). The different cellular localization patterns suggest these Raf members play 
isoform specific roles, although originally they were thought to be functional redundant to 
some extent.  
       BRaf isoform specific features: Compared with ARaf and CRaf, BRaf has a higher 
basal activity and is more liable to oncogenic mutation. Somatic mutations of BRaf were 
frequently found in different human cancers (~83%anaplastic thyroid carcinoma, and 55-68% 
malignant melanoma). Particularly, a substitution of Val599 with Glu (BRafV599E) accounts 
for ~90% oncogenic BRaf mutations in cancers (SRIKALA et al., 2005). BRafV599E is 
constitutively active, and its activity appears to be independent of Ras binding. Crystal 
structure of BRaf kinase doman indicates that the V599E mutation may eliminate the 
requirement for activation segment phosphorylation. Surprisingly, some BRaf mutants with 
impaired kinase activity can activate CRaf and signal to ERK in cells, suggesting that BRaf 
may function as a scaffold protein (WAN et al. 2004).  Furthmore, over-expression of wild 
type BRaf in malignant melanoma without NRas mutation can activate MAPK signal and 
promote cell growth (TANAMI et al. 2004), indicating that BRaf may have an intrinsic 
potential to activate CRaf (or other BRaf molecules). These studies highlight the importance 
and physiological significance of BRaf. Thus, understanding isoform-specific functions and 
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regulatory mechanisms of BRaf has been attracting more research interest. 
      The negative charged motif (D447-D448) preceding the kinase domain is a BRaf specific 
feature. As mentioned already, the corresponding sites in ARaf and CRaf must be 
phosphorylated by Src kinases to achieve full activation. However, the negative charged 
motif in BRaf mimics constitutive phosphorylation and may account for BRaf’s high basal 
activity (OHTSUKA, et al. 1996; MASON et al. 1999).   
      Different from ARaf and CRaf, BRaf has an extended N-terminus in addition to CR1, 
CR2 and CR3. However, studies of BRaf regulation have mainly focused on CR1, CR2 and 
CR3 with little attention, thus far, given to the role of this BRaf specific N-terminal region. 
Although Fischer et al. (2007) found this extended N-terminus facilitated BRaf’s interaction 
with HRas in vitro, at the present time, the molecular mechanisms are not clear and the 
biological implications of this BRaf specific N-terminal region in vivo are not well defined. 
       Drosophila Raf: Drosophila has one Raf gene encoding DRaf protein. As a key 
component of the MAP kinase signaling module, DRaf plays an essential role in numerous 
receptor tyrosine kinase (RTK) pathways in Drosophila development. The regulatory 
mechanisms of DRaf are quite similar to that of mammalian Raf proteins. Almost all the 
regulators, co-factors as well as effectors of DRaf are conserved in mammals.  Forward 
genetics screen for components of Ras-Raf-MAPK pathway in Drosophila have 
tremendously advanced our understanding of the signaling in mammals, and study of DRaf 
have been providing lots of important clues regarding to regulator mechanisms of 
mammalian Raf proteins.   
Based on the primary structures, Drosophila Raf is more similar to BRaf than either 
ARaf or CRaf. DRaf has 61% overall sequence similarity with BRaf. DRaf shares isoform 
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specific features with BRaf and is thought to be a BRaf ortholog. DRaf has the signature 
negative charged motif (E420-E421) that corresponds to D447-D448 within BRaf (MASON et 
al. 1999; MISHRA et al. 2005).  DRaf also has an extended amino-terminus followed by CR1. 
DRaf and BRaf also share parallels in their modes of regulation. Rap1 can activate both BRaf 
and DRaf, but not ARaf or CRaf (MISHRA et al. 2005; OHTSUKA, et al. 1996). Therefore, 
studies on DRaf using the powerful Drosophila genetic system may provide important unique 
insights to better understand the functional roles and regulatory mechanisms of BRaf. 
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Figure Legends 
FIGURE I-1. Raf-mediated Receptor Tyrosine Kinase (RTK) signal pathways: The 
binding of ligand to a RTK receptor triggers the activation of small GTPase Ras, which 
recruits Raf to the plasma membrane. Once activated, Raf transfers its signal to MEK, in turn 
leading to activation of ERK.  By regulating downstream gene expression, the RTK 
pathways function in numerous fundermental processes, including differentiation, 
proliferation, cell survival and cell fate determination. 
        FIGURE I-2. Schematic representations of Raf kianses: Raf family members share a 
common primary structure consisting of three conserved regions (CR1, CR2 and CR3). CR1 
contains a Ras-binding domain (RBD) and a cysteine-rich domain (CRD), and is required for 
recruitment of Raf to the plasma membrane. The Ser/Thr-rich region CR2 has a 14-3-3 
binding site. CR1 and CR2 represent the regulatory half of the Raf protein, while the 
catalytic portion of the kinase is located in the C-terminal conserved region 3 (CR3). In 
addition to CR1, CR2 and CR3, BRaf and DRaf contain an extended N-terminal segment 
followed by CR1. 
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Abatract 
Drosophila Raf (DRaf) contains an extended N-terminus, in addition to three conserved 
regions (CR1-3), however, the function(s) of this N-terminal segment remains elusive. In this 
paper, a novel region within DRaf's N-terminus that is conserved in BRaf proteins of vertebrates 
was identified and termed Conserved Region N-terminal (CRN). We show that the N-terminal 
segment can play a positive role(s) in the Torso receptor tyrosine kinase pathway in vivo, and its 
contribution to signaling appears to be dependent on the activity of Torso receptor, suggesting 
this N-terminal segment can function in signal transmission. Circular dichroism analysis 
indicates that DRaf’s N-terminus (amino acids 1-117) including CRN (amino acids 19-77) is 
folded in vitro and has a high content of helical secondary structure as predicted by proteomics 
tools. In yeast two-hybrid assays, stronger interactions between DRaf’s Ras binding domain 
(RBD) and the small GTPase Ras1, as well as Rap1, were observed when CRN and RBD 
sequences were linked. Together, our studies suggest that DRaf’s extended N-terminus may 
assist in its association with the upstream activators (Ras1 and Rap1) through a CRN-mediated 
mechanism(s) in vivo.    
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Introduction 
Evolutionarily conserved receptor tyrosine kinase (RTK) signaling pathways function in 
fundamental cellular processes including differentiation, proliferation and cell survival in 
eukaryotes (SCHLESSINGER 2000). The Raf serine/threonine kinase, as a key component of 
RTK signaling modules, plays a central role in transmitting upstream stimuli to the nucleus 
(DAUM et al. 1994). Cyclic control of Raf depends on activities of GTPases, kinases, 
phosphatases and scaffold proteins (CHONG et al. 2001; DHILLON et al. 2002; KOLCH 2000; 
MORRISON 2001; RAABE and RAPP, 2002). Clues to these regulatory events were derived 
from the identification of conserved regions/motifs/sites. However, the mechanisms that 
modulate Raf serine/threonine kinases are complicated and remain elusive.     
Mammals have three Raf isoforms, ARaf, BRaf and CRaf. They share a similar primary 
structure consisting of three conserved regions (CR1, CR2 and CR3). Conserved region 1 
(CR1), where a Ras binding domain (RBD) and a cysteine-rich domain (CRD) reside, is 
required for Ras-Raf interaction. CR2, a serine/threonine-rich region, contains a 14-3-3 
binding site. CR1 and CR2 are embedded in the regulatory N-terminal half of Raf proteins, 
while CR3, including the catalytic kinase region and an additional 14-3-3 binding site, 
resides in the C-terminus (Reviewed by WELLBROCK et al. 2004). In addition to these three 
conserved regions, BRaf has an extended amino-terminal segment followed by CR1 (TERAI 
and MATSUDA 2006; FISCHER et al. 2007). However, studies of BRaf regulation have mainly 
focused on CR1, CR2 and CR3 with little attention, thus far, given to the role of this N-
terminal region.  
Translocation of Raf proteins to the plasma membrane, a critical step in their activation, 
can be mediated through different mechanisms. It is reported that direct interaction between a 
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basic motif in CRaf’s kinase region and phosphatidic acid (PA) can recruit Raf to the 
membrane (RIZZO et al. 2000; KRAFT et al. 2008). This PA-binding site is conserved in 
ARaf and BRaf proteins. Also, association with Ras, a major regulator of Raf kinases, plays a 
crucial role(s) in translocation and activation of Raf.  However, the molecular mechanisms of 
Ras-Raf coupling are not completely understood. Raf’s RBD can directly interact with the 
switch 1 region of GTP-Ras and is thought to be the core element for Ras binding (NASSAR 
et al. 1995). CRD is involved in Ras-Raf coupling, as well, through interaction between its 
hydrophobic patch and the lipid moiety of Ras (WILLIAMS et al. 2000; THAPAR et al. 2004). 
Thus, both RBD and CRD contribute to Ras-Raf interaction and the effects are likely 
additive. Disabling either RBD or CRD is thought to reduce but not completely eliminate Raf 
activity (HU et al. 1995). Recently, Fischer et al. (2007) found BRaf’s interaction with HRas 
was also facilitated by the extended N-terminus, in vitro. At the present time, however, the 
identity of residues/sites that participate in this process are unknown and the biological 
implications of this N-terminal region in vivo have not been defined.      
Drosophila has one Raf gene first described genetically as l(1) pole hole, and later 
referred to as DRaf or Raf. As a member of the MAP kinase signaling module, DRaf plays an 
essential role in numerous receptor tyrosine kinase (RTK) pathways in Drosophila 
development (BRENNAN and MOSES 2000; VAN BUSKIRK and SCHÜPBACH 1999; DUFFY 
and PERRIMON 1994; RAABE 2000).  Based on its primary structure, the DRaf protein is 
more similar to BRaf than either ARaf or CRaf (DHILLON and KOLCH 2002; CHONG et al. 
2003; MORRISON and CUTLER 1997).  DRaf and BRaf have two acidic residues (E420-E421 
in DRaf; D447-D448 in BRaf) preceding the kinase region that correspond to residues Y301-
Y302 in ARaf and Y340-Y341 in CRaf, respectively. These negative charged acidic residues 
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mimic constitutive phosphorylation and are thought to be related to the higher basal activity 
of BRaf (MASON et al., 1999; MISHRA et al. 2005). Both DRaf and BRaf have an extended 
amino-terminus, when compared to ARaf and CRaf, in addition to CR1, CR2 and CR3.  
DRaf and BRaf also share parallels in their modes of regulation.  Rap1 can activate both 
BRaf and DRaf, but not ARaf or CRaf (MISHRA et al. 2005; OHTSUKA, et al. 1996). Like the 
Raf proteins in mammals, the activity of DRaf is regulated through 
phosphorylation/dephosphorylation (BAEK et al. 1996; LABERGE et al. 2005; RADKE et al. 
2001; ROMMEL et al. 1997), interaction with scaffold proteins or other binding partners 
(DOUZIECH et al. 2003; DOUZIECH et al. 2006; ROY et al. 2002; ROY and THERRIEN 2002; 
ROIGNANT et al. 2006; RAJAKULENDRAN et al. 2008).  These regulatory events occur within 
the three conserved regions (CR1-3) of DRaf, however, the role of DRaf’s N-terminal region 
has not been elucidated.      
Development of both embryonic termini in Drosophila is dependent on DRaf-mediated 
Torso RTK signaling. Binding of Trunk or Torso-like with the Torso receptor initiates Ras1-
DRaf-MEK signaling at the poles of early staged embryos, and in turn, triggers expression of 
at least two gap genes, tailless and huckebein, which specify terminal structures and help to 
establish segmental identities in the embryo (Reviewed by FURRIOLS and CASANOVA 2003). 
The domain of tailless (tll) expression in the embryonic posterior region has been used as a 
quantitative marker to measure the strength of the Torso RTK signal in early embryos. At the 
cellular blastoderm stage, embryos from wild type mothers show posterior tll expression 
from approximately 0-15% embryo length (EL). At a later stage embryos exhibit normal 
internal head structures, three thoracic segments (T1-T3), eight abdominal denticle belts (A1-
A8), as well as the Filzkörper tail structure. Decreased or loss of Torso RTK pathway activity 
 22
results in a reduced posterior expression domain of tll and consequently absence of 
embryonic tail structures. In contrast, gain-of-pathway activity can lead to expanded tll 
expression domains at both poles, and subsequently enlarged head and tail structures, 
accompanied by deletion of central abdominal segments (GHIGLIONE et al. 1999; JIMÉNEZ et 
al. 2000).     
 In this study, using the Drosophila embryonic termini as both a qualitative and 
quantitative in vivo assay system, we examined the role played by DRaf’s N-terminus in 
Torso signaling in different genetic backgrounds. We observed a subtle, but consistent, 
higher signaling potential for full-length DRaf proteins when compared with those lacking 
amino-terminal residues 1-114 (DRaf$N114). Furthermore, a novel region within DRaf’s N-
terminus that is conserved in RAF genes of most invertebrates and BRaf genes of vertebrates 
was identified and termed Conserved Region N-terminal (CRN). Our studies suggest that 
DRaf’s extended N-terminus may assist in its association with the upstream activators (Ras1 
and Rap1) in vivo and thus, potentially play a regulatory role(s) in DRaf’s activation through 
a CRN-mediated mechanism(s).  Minor adjustment by CRN on Ras1 and Rap1 binding may 
help to fine-tune DRaf’s activity and consistently provide optimal signal output. 
 
Materials and Methods 
Drosophila strains and genetics: In this study, y w, Draf 11-29 (Draf  -; DRaf protein null, 
MELNICK et al. 1993), trunk1 (trk -; loss-of-function allele, lacks C-terminal 16 amino acids, 
SCHÜPBACH and WIESCHAUS 1989, CASANOVA et al. 1995), torsoXR1 (tor -; Torso protein 
null allele, tor gene deletion, SPRENGER et al. 1989), and torsoRL3 (torRL3; gain-of-function 
allele, H242L amino acid replacement in the extracellular domain, SPRENGER et al. 1993) 
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strains were used. The “FLP-DFS” technique was utilized to generate Draf 11-29 germline 
clones (CHOU and PERRIMON 1996). Drosophila stocks were raised at 25! on standard 
cornmeal medium. To study the gain-of-function effects of the temperature-sensitive torRL3 
allele (Figure II-3), virgin females were collected and mated with wild type males at 25! for 
3-4 days and then moved into a 29! incubator. Eggs were collected at 29! during the first 1-2 
days for western analysis and phenotypic characterization.     
Transgene design: Full-length and truncated DNAs were amplified using wild type 
DRaf cDNA (GenBank#AY089490, obtained from Drosophila Genomics Research Center) 
as template, and inserted into the polylinker site of the P-element transformation vector 
pCaSpeR-HS83. The full-length cDNA sequence (FL DRaf) encodes a DRaf protein with 
739 residues, while the truncated cDNA sequence (DRaf$N114) corresponds to amino acid 
115-739 of the FL DRaf protein. The constitutively active heat-shock 83 gene (HS83) 
promoter was used to drive the expression of DRaf transgenes to simplify the generation of 
transgenic lines with various genetic backgrounds. Transgenic lines were generated by 
Genetic Services (Sudbury, MA). 
Multiple lines derived for each transgene were used in this study. DRaf$N114 (L1, #a and 
#b), FL DRaf (#a and #b) were used to generate germline clone bearing females (Figure II-1). 
Lines #1, #2, #3 of DRaf$N114 and #1, #2, #3 of FL DRaf were used in torRL3, trk1 and torXR1 
backgrounds. The DRaf$N114 line #1 is homozygous lethal, thus we generated trk1/trk1; 
DRaf!N114#1/ DRaf!N114#3 and torXR1/torXR1; DRaf!N114#1/DRaf!N114#3 lines that produce 
DRaf protein levels equivalent with other lines (Figure II-4, Table II-1).      
Western analysis: To produce protein extracts, 100 eggs were collected and 
homogenized in 36ul lysis buffer containing 20mM Tris-Cl (pH8.0), 150mM sodium 
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chloride, 0.2% Triton-X 100, 0.2% Nonidet P-40, 10mM EDTA, 1mM EGTA, 1mM 
phenylmethylsulfonyl fluoride, 0.15U/ml aprotinin and 20mM leupeptin. Insoluble material 
was removed by centrifugation (13000 rpm, 10 minutes) at 4 !C. Protein extracts were 
separated by 8% SDS-PAGE, and electrophoretically transferred to nitrocellulose membrane. 
DRaf proteins were probed with rabbit anti-Raf antibody (70.1, SPRENGER et al. 1993) and 
horseradish peroxidase-coupled goat anti-rabbit secondary antibody (Thermo Scientific). !-
tubulin proteins probed with mouse antibody (Sigma) and horseradish peroxidase-coupled 
goat anti-mouse secondary antibody (Thermo Scientific) were used as an internal control. 
The membranes were developed using SuperSignal West Pico kit (Thermo Scientific). 
Protein level was quantified with Image J.            
In situ hybridization: tailless and engrailed probes were generated from wild type 
cDNA clones (tailless: Genebank #BT022195; engrailed: Genebank #AY069448, obtained 
from the Drosophila Genomics Research Center) using the PCR DIG probe synthesis kit 
(Roche Applied Science). Whole-mount mRNA in situ hybridizations were performed in 
embryos according to the protocol of Tautz and Pfeifle (1989) with minor modifications.     
Circular dichroism (CD) spectral measurement: DNA corresponding to amino acids 
1-117 of DRaf (DRafN117) was recombined into the pGEX vector. The GST-DRafN117 fusion 
protein was produced by expression in E.coli BL21, and purified by standard affinity 
chromatography. Purified GST-DRafN117 protein was digested with thrombin. The DRafN117 
protein (~13KD) was purified by a size-exclusive column (Amersham Biosciences), and 
verified by Mass spectra and N-terminal sequencing. Protein sample (0.05 mg/ml in 10 mM 
sodium phosphate buffer) was loaded to 0.1 cm quartz CD cuvette. CD spectra was measured 
by Jasco J-710 spectropolarimeter (Protein facility at Iowa State University) at room 
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temperature. Data were collected with 0.2 nm resolution and at a scan rate of 1.5 nm min-1. 
The ellipcity value of the blank buffer at each wavelength was substracted from each point.      
Yeast two-hybrid analysis: The R174 to L mutation in DRaf (DRafR174L) was 
generated by PCR-based site-directed mutagenesis, and confirmed by sequencing. DNA 
sequences corresponding to amino acid 1-117 (N), 1-212 (NRBD), 18-212 ($17NRBD), 78-
212 ($77NRBD) and 115-212 (RBD) were obtained by PCR using wild type DRaf as the 
template, while DNAs encoding NRBDR174L and RBDR174L were amplified from DRafR174L 
DNA. Amplified DNAs were cloned into pGADT7 vector (Clontech).  DNA sequences 
encoding amino acid 1-183 of Ras1 (Ras1$CAAX), 1-180 of Rap1 (Rap1$CAAX) were 
amplified from cDNAs of wild type Ras1 and Rap1 (Ras1: Genebank #AF186648; Rap1: 
NCBI Reference #NM_057509, obtained from the Drosophila Genomics Research Center) 
respectively, and inserted into the pGBKT7 vector (Clontech).  
Constructed pGADT7 and pGBKT7 plasmids were transformed into yeast Y187 strain. 
Protein-protein interactions were tested by ß-Galactosidase assays using X-gal (5-bromo-4-
chloro-3-indolyl-b-D-galactopyranoside, Sigma; solid-support assay) or ONPG (ortho-
nitrophenyl-b-D-galactopyranoside, Sigma; liquid quantitative assay) as substrates. ß-
Galactosidase units in quantitative assays were calculated according to the Yeast Protocol 
Handbook (Clontech). All yeast two-hybrid experiments are confirmed by reciprocal bait-
prey assays and repeated at least 4 times.  
 
Results 
To study the potential function of DRaf’s N-terminal residues (amino acids 1-114), we 
generated transgenic flies expressing full-length DRaf (FL DRaf) or DRaf proteins lacking 
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amino-terminal residues 1-114 (DRaf$N114; Figure II-1A). The constitutive heat-shock 83 
(HS83) promoter was selected to drive transgene expression, to simplify the generation of 
complex genetic backgrounds required to test the functionality of N-terminal residues. We 
used the Torso pathway to test the signaling potential of these maternally expressed DRaf 
proteins. Since the Torso signaling system is solely dependent on activity of maternal DRaf 
proteins, we could readily determine and verify the quantity of DRaf proteins available for 
Torso signal transduction in early staged embryos by western blot analysis. Thus, at 
equivalent protein concentrations, we compared the signal potential of FL DRaf and 
DRaf$N114 proteins to characterize the role of the N-terminus in a well-defined RTK pathway 
in vivo.  
DRaf’s N-terminus can contribute to RTK signaling in Drosophila embryos:  
Embryos that were deficient for maternal DRaf protein (derived from Draf11-29/Draf11-29 
female germ cells, see MATERIALS and METHODS) lack posterior tll expression at ~2.5 
hours after egg deposition and subsequently exhibit abnormal cuticle pattern with deletion of 
posterior structures due to loss of Torso RTK signaling (Figure II-1D ii, ii’). We generated 
females with germ cells homozygous mutant for the Draf 11-29 allele (Draf -/ -) but expressing 
FL DRaf or DRaf$N114 proteins using the “FLP-DFS” technique (CHOU and PERRIMON, 
1996). Cuticles of embryos produced by Draf  -/ -; DRaf !N114 female germline clones 
expressing maternal truncated proteins at % to endogenous wild type DRaf levels were 
essentially equivalent to those of wild type embryos with only one (1/245) lacking posterior 
Filzkörper (line L1, Figure II-1B, E). However, when DRaf $N114 was expressed at low 
maternal levels (~ 1/4 of endogenous DRaf level; 2 independent transgenic lines #a and #b; 
Figure II-1B), ~4.5% of the embryos assayed lacked posterior Filzkörper (Figure II-1D iii, E). 
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At such a reduced expression level (2 independent lines #a and #b, Figure II-1B), FL DRaf 
showed rescue of posterior pattern with Filzkörper development observed for a higher 
percentage of embryos (~98.5%, &2=9.91976318, P<0.01; Figure II-1D, E). In agreement 
with the cuticle phenotype, an abnormal posterior tll expression pattern (<13% EL) was 
observed more often for embryos that inherited truncated DRaf$N114 (78.8%, n=52) rather 
than full-length DRaf proteins (91%, n=78; &2=3.9386844, P<0.05, Figure II-1D), suggesting 
that DRaf$N114 was less active than FL DRaf in Torso RTK signaling.       
To test our protein quantification assay, a more rigorous examination was conducted 
using western blot analysis. Three samples representing lystes of 6, 12, and 18 eggs from 
each line (Draf  -/ -; DRaf !N114#a and Draf  -/ -; FL DRaf #a) were loaded on to a SDS-PAGE 
gel. As shown in Figure II-2A, the intensity of DRaf and corresponding tubulin bands 
exhibits a roughly linear correlation with the number of eggs lysed (Figure II-2B). In addition, 
the normalized DRaf protein level was consistent among the three samples loaded for the 
same transgenic line (Figure II-2C), suggesting our western blots analysis was reliable. 
Importantly, we also addressed the question of maternal DRaf protein stability and whether 
deletion of the N-terminal region altered DRaf accumulation levels during Torso signal 
transduction.  Embryonic lysates from eggs collected at 0-1, 1-2 and 2-3 hours after 
deposition were prepared (Draf  -/ -; DRaf !N114#a and Draf  -/ -; FL DRaf #a ). As shown in 
Figure II-2D and E, DRaf protein levels remained roughly constant, indicating both FL DRaf 
and DRaf$N114 proteins are stable throughout the 0-3 hour period when the Torso pathway is 
active.   
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Next, we genetically altered the Torso pathway to create a sensitized signaling 
environment and compared the potential of DRaf$N114 and FL Raf proteins in this 
background. torRL3 is a temperature-sensitive, recessive, gain-of-function allele of the Torso 
receptor. At the non-permissive temperature 25-29°, torRL3/torRL3 mothers produce embryos 
that show broad tll expression at both anterior and posterior ends. These embryos develop 
and show deletion of central abdominal segments, and do not hatch (STRECKER et al. 1989). 
Eggs derived from females heterozygous for torRL3 (torRL3/+) can hatch as larvae, however, 
some of these larvae show a gain-of-function phenotype with deletion of an abdominal 
segment(s). At 29°, we found 7.4% (n=553, Figure II-3D) of the larvae from torRL3/+ mothers 
showed deletion, fusion or broken abdominal denticle bands. In this genetic background, 
when expressed at comparable protein levels (Figure II-3A, B), FL DRaf enhanced the torRL3 
phenotype much more significantly than DRaf$N114, resulting in a greater number of embryos 
with central abdominal defects. We found 31.8% (n=422) embryos with FL DRaf proteins 
showed the gain-of-function phenotype (Figure II-3C, D), while only 17.1% (n=450) of the 
DRaf$N114 embryos showed such defects (Figure II-3C, D). We repeated these experiments 
using two additional, independently derived transgenic FL DRaf and DRaf !N114 lines and 
observed similar results (&2=51.063876, P<0.001; Figure II-3D). 
To test if the cuticle phenotypes observed were due to alterations in the embryonic fate 
map, we determined the mRNA accumulation pattern for the engrailed (en) segmentation 
gene in ~ stage 11 embryos. The en mRNA wild type pattern is dependent on normal 
signaling in the Torso pathway. We found 36.1% (n=169) of the embryos from torRL3/+; FL 
DRaf mothers had at least one deleted, fused or broken en central abdominal stripe(s) (Figure 
II-3E iv). The segmentation defects observed were most likely due to the expansion of head 
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and/or tail domains and indicative of the gain-of-function phenotype. In contrast, only 33 of 
141 (23.4%) embryos from torRL3/+; DRaf !N114 mothers had such defects (&2=6.38030206, 
P<0.02). Consistent with the cuticular phenotypes and en expression patterns, expansion in 
the domain of tll expression was observed more often for embryos from torRL3/+; FL DRaf 
mothers (32.0%, n=50) compared with those from torRL3/+; Draf !N114 females (13.1%, n=76; 
&2=5.50220096, P<0.02, Figure II-3E iii’, iv’). Together, these in vivo studies consistently 
indicated that deletion of the N-terminus reduces the ability of DRaf to enhance the ectopic 
gain-of-function effects of torRL3 and that these N-terminal residues could participate in 
Torso RTK signaling.     
The contribution of DRaf’s N-terminus to signaling appears to be dependent on the 
activity of the Torso receptor: Embryos lacking normal maternal Trunk (Trk) activity show 
little or no posterior tll expression (occasionally, trace-level tll expression was detected in 3-4 
cells at the posterior embryo tip) and exhibit an abnormal expression pattern for the engrailed 
(en) segmentation gene. Instead of 3 thoracic and 9 abdominal en stripes as observed for 
embryos from wild type mothers (Figure II-4C i’), these Trk-deficient embryos have 3 
thoracic and only 6-7 abdominal en stripes (Figure II-4C ii’), and exhibit terminal defects 
with deletion of all posterior structures (A8 denticle belt and Filzkörper; Figure II-4C ii). 
Interestingly, overexpression of FL DRaf partially restores the A8 denticle belt structure in 
embryos from trunk1/trunk1 (trk -/ -; lacks the last 16 amino acids) mothers (Figure II-4C iv). 
This result is consistent with our unpublished findings (K. H. BAEK and L. AMBROSIO) using 
the trk3 allele (encodes the first 89 amino acids) and a different method. Rescue of posterior 
structures for some Trk-deficient embryos was found after injection of wild type DRaf 
mRNA, also suggesting that accumulation of exogenous DRaf proteins promotes signaling in 
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this trk - background. However, expression of the DRaf !N114 transgene at a similar level failed 
to rescue the A8 denticle band defect in embryos from trk -/ - mothers (Figure II-4 A, C iii). 
We repeated these experiments using two additional FL DRaf and DRaf !N114 transgenic lines 
and observed similar results (&2=82.8574882, P<0.001; Figure II-4D). Thus, FL DRaf appears 
to possess greater activity compared with DRaf$N114. To test if these cuticle phenotypes were 
correlated with segmentation gene expression, we examined the accumulation of en mRNA 
in early gastrulating embryos. All embryos from trk -/ -; DRaf !N114/DRaf !N114 mothers had 3 
thoracic and only 6-7 abdominal en stripes (Figure II-4C iii’), while some embryos (12.5%, 
n=24) derived from trk -/ -; FL DRaf/FL DRaf females had 3 thoracic and 8 abdominal en 
stripes (&2=3.97058824, P<0.05; Figure II-4C iv’). This indicated that addition of FL DRaf 
but not DRaf$N114 proteins partially restored posterior Torso RTK signaling in the trk - 
background. Consistent with this hypothesis, as shown in Figure II-4C iii’’ and iv’’, partial 
rescue of posterior tll mRNA expression was detected in some cellular blastoderm embryos 
derived from trk -/ -; FL DRaf/FL DRaf females (8.1%, n=37) but not for those derived from 
trk -/ -; DRaf !N114/DRaf !N114 mothers (n=52, &2=4.36329353, P<0.05). Together, these data 
consistently suggest that the absence of the N-terminal segment reduces the signaling 
potential of DRaf and the N-terminus can contribute to Torso RTK terminal signaling in a 
positive manner. 
Sprenger et al. (1993) previously observed a low level of Torso receptor 
phosphorylation in eggs derived from trk loss-of-function, but not tor loss-of-function 
females. Therefore, a small amount of Torso signal activity may exist in our trk – background. 
This may be due to 1.) the presence of active Torso-like (Tsl) ligand, 2.)potential residual 
Trunk activity, considering the molecular lesion of the trk1 allele we used (lacks only the last 
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16 amino acids), or 3.) the intrinsic activity of the Torso receptor. This activity could allow 
rescue of posterior structures by FL DRaf expression. If so, the contribution of the N-
terminus to terminal signaling is likely sensitive to such upstream events. Thus, we examined 
the consequences of DRaf expression in embryos from torXR1/torXR1 (tor -/ -; protein null) 
mothers that lacked the Torso receptor. We found that expression of FL DRaf or DRaf$N114 
failed to restore terminal structures for these embryos (Table II-1). This indicates the 
contribution of DRaf’s N-terminal residues to signaling is dependent on activity of the 
receptor. 
The N-terminus of DRaf contains a novel conserved region and has a high content 
of helical secondary structure: We analyzed the amino acid sequence of DRaf’s N-terminus 
using several bioinformatics tools, to obtain hints regarding its structure, and perhaps 
mechanism(s) of its functional role(s). A PROSITE motif search showed a putative protein 
kinase C (PKC) phosphorylation site within the “T-S-K” motif of the N-terminus (positions 
60-62; SIGRIST et al. 2002).  Phosphorylation site prediction by NetPhos 2.0 suggested that 
the Thr in this “T-S-K” motif had a high phosphorylation potential (Figure II-5A; BLOM et al. 
1999).  Predictions of secondary structure for the N-terminal region using GORV, PHD and 
Predator indicated a high "-helical propensity (Figure II-5A; FRISHMAN and ARGOS 1996; 
ROST et al., 1994; GARNIER et al., 1996; COMBET et al. 2000).       
A blastp search of other organisms with DRaf’s N-terminal sequence identified 
honeybee Raf, chick C-Rmil, and BRaf proteins of sea urchin, zebrafish, frog and human. 
The region containing amino acid 19 to 77 of DRaf showed homology between candidates.  
These sequences were aligned using ClustalW, and are shown in Figure II-5A (COMBET et al. 
2000).  Overall, the amino acids showed 18.6% identity and 47.5% similarity, and we term 
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this region CRN, Conserved Region N-terminal. Interesting features of CRN include the 
putative phosphorylation site, and a propensity to form two "-helical structures. This 
suggests that the N-terminal region of DRaf may have function(s) shared by other BRaf 
proteins.  
The conserved structural features, including "-helical propensity, may be related to the 
functional role(s)/regulatory mechanism(s) of DRaf’s N-terminus. To confirm the prediction 
attained by bioinformactics tools, circular dichroism (CD) spectral measurement of the N-
terminal part of DRaf (amino acid 1-117, DRafN117) was performed after its expression and 
purification in vitro (see MATERIALS and METHODS). As shown in Figure II-5B, a 
bilobed spectrum with local minima at ~209.4 nm and at ~221.4 nm was observed, indicating 
the relatively high content of helical secondary structure for DRaf’s N-terminus. The 
estimated helix content of DRaf N117 is ~77% based on the CD spectra data analysis using 
DICHROWEB (WHITMORE, et al., 2008, http://dichroweb.cryst.bbk..ac.uk/html/home.shtml). 
This result bolsters the predictions by GORV, PHD and Predator.     
The N-terminus assists in association of DRaf’s RBD with small GTPases Ras1 and 
Rap1 in vitro: Fischer et al. (2007) found that association of BRaf with HRas was facilitated 
by N-terminal sequences, in vitro. To examine if the presence of DRaf’s N-terminus can 
affect Ras1 binding, we tested interaction between Ras1$CAAX and DRaf’s RBD (Ras 
binding domain) using the yeast two-hybrid assay. A stronger interaction with Ras1$CAAX 
was detected when N-terminal residues were linked to RBD in both solid-support (data not 
shown) and liquid quantitative ß-Galactosidase assays (P<0.05, t test; Figure II-6B), 
suggesting that the N-terminus may assist in association of DRaf with Ras1.  This is 
consistent with results obtained for BRaf (FISCHER et al. 2007). 
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No direct interaction was detected between Ras1$CAAX and isolated N-terminal 
residues of DRaf (Figure II-6B, and solid-support data not shown). Thus, the N-terminus 
appears to contribute to Ras1 binding, but as an isolated protein fragment cannot directly 
interact with Ras1. Arg174 located in DRaf’s RBD region is essential for its association with 
Ras1 and substitution of Arg174 to Leu in RBD (RBDR174L) abolishes Ras1 binding (FABIAN 
et al. 1994; LI et al. 1998). We found that N-terminal residues cannot restore Ras1 
interaction when linked with RBDR174L (Figure II-6B, and solid-support data not shown). 
This indicated the effects of the N-terminus were dependent on interaction between RBD and 
Ras1.   
Moreover, we tested the idea that the conserved CRN region (19-77) might be essential 
for the contribution of DRaf’s N-terminus to Ras1$CAAX binding. Deletion of the first 
seventeen N-terminal amino acids ($17NRBD) did not change Ras1$CAAX binding. 
However, if N-terminal amino acids including CRN were removed ($77NRBD), interaction 
with Ras1$CAAX was reduced to a level similar to that observed by deletion of the entire N-
terminus (amino acids 1-114; Figure II-6A, B). Together, these findings suggested the 
hypothesis that N-terminal residues of DRaf can assist in Ras1 interaction through a CRN-
mediated mechanism(s).     
The small GTPase Rap1, a close relative of Ras1, is known to interact with DRaf and 
play a role in Torso RTK signaling in vivo (MISHRA et al. 2005). To examine if DRaf’s N-
terminus affects its association with Rap1, we tested interaction between Rap1$CAAX and 
DRaf’s RBD (Figure II-6C).  A stronger interaction with Rap1$CAAX was detected when 
the N-terminus was linked to RBD, similar to our findings with Ras1 (P<0.05, t test). 
Furthermore, the conserved CRN region (19-77) seems essential for the contribution of the 
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N-terminus to this interaction with Rap1, suggesting a CRN-mediated mechanism(s) may be 
a general feature for its binding to both Ras1 or Rap1.  
 
Discussion 
In our study, a novel region (amino acids 19-77) within DRaf's N-terminus, conserved 
for Raf genes of most invertebrates and BRaf genes of vertebrates, was identified and termed 
Conserved Region N-terminal (CRN). This conserved region has not been described by 
others, but potential roles for the extended N-terminus have been proposed in two reports. 
Terai and Matsuda (2006) found that in Hela cells, the N-terminus of BRaf may mediate Raf 
dimerization to generate BRaf-BRaf or BRaf-CRaf complexes, and play an important 
regulatory role in calcium-induced BRaf activation. However, Fischer et al. (2007) reported 
that deletion of BRaf’s N-terminus did not affect BRaf-CRaf dimer formation. Instead, they 
found that N-terminal residues appeared to facilitate interaction with HRas in vitro. In 
accordance with their data, stronger interactions between DRaf’s RBD (Ras binding domain) 
and the small GTPase Ras1$CAAX were observed when N-terminal and RBD sequences 
were linked in our yeast two-hybrid analysis. This suggested that the N-terminus might assist 
in Ras1 binding. Furthermore, the identity of specific residues in the N-terminus that might 
participate in Ras1 binding were mapped to the CRN region (amino acid 19-77). Two known 
Raf motifs, RBD and CRD (cysteine rich domain), are involved in Raf’s interaction with Ras. 
Our studies, and results obtained by Fischer et al. (2007) using BRaf, suggest that the N-
terminal residues of DRaf and BRaf proteins, particularly the CRN region, might be another 
element that plays a role(s) in Ras-Raf coupling.   
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The small GTPase Rap shares with Ras nearly identical Raf binding regions that 
comprise switch 1 and the lipid moiety (HARIHARAN 2005). Rap functions as an antagonist 
of Ras in regulating CRaf activity (COOK et al. 1993), but can activate BRaf in a parallel way 
with Ras (OHTSUKA et al. 1996). Isoform-specific features of different Raf family members 
may explain their distinct responses to Rap. In flies, both Ras1 and Rap1 can interact with 
and activate DRaf (MISHRA et al. 2005). Thus, it was reasonable to test whether DRaf’s N-
terminus including CRN might also assist in Rap1 binding. In agreement with this idea, 
stronger interaction between RBD and Rap1$CAAX was observed when DRaf’s CRN and 
RBD sequences were linked in vitro, further suggesting that the N-terminus may contribute 
to both Ras1 and Rap1 binding potentially through a CRN-mediated mechanism(s) in vivo.  
What is the molecular mechanism(s): No direct interaction between Ras1 or Rap1 and 
the isolated DRaf N-terminal segment (amino acids 1-117) was detected, or when the N-
terminus was linked with the Ras1/Rap1 binding-deficient RBDR174L. Thus, the contribution 
of DRaf’s N-terminal residues to Ras1 and Rap1 binding requires the presence of RBD. It is 
possible that the CRN-containing N-terminus may assist in Raf-Ras interaction by making 
RBD more accessible to Ras1 and/or in a sequential manner, subsequent to RBD-Ras1 
interaction, by stabilizing the RBD-Ras1 complex. Deletion of CRN may result in 
conformational or structural changes that reduce Ras1 binding affinity. Structural analysis of 
these complexes may provide important clues and help to understand the molecular 
mechanism(s) by which CRN assists in Ras-Raf interaction. Our computational analysis 
suggested conserved CRN has the propensity to form two "-helical structures ("1 and "2; 
Figure II-5A) and contains a putative phosphorylation motif “T-S-K” located in "2. In 
agreement, DRaf’s N-terminus (amino acids 1-117) was folded in vitro and had a high 
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content of helical secondary structure (Figure II-5B). These findings may help to establish a 
basis for future determination of molecular structure.   
Although no verified binding partner(s) for DRaf or BRaf’s N-terminus has been 
identified, it is still possible that CRN may interact with other regulatory factors in vivo, that 
may affect Ras or Rap binding and/or function in activation of DRaf and BRaf. If so, the 
conserved structural features of CRN most likely relate to these regulatory events in vivo. 
Site-directed mutagenesis of conserved sites/motifs could provide useful information 
regarding the molecular mechanism(s) of CRN’s role in the activation of DRaf and BRaf. 
Torso RTK signal is differentially elevated by overexpression of FL DRaf and 
DRaf!N114 in vivo: We initiated our in vitro studies of DRaf’s N-terminus based on our in 
vivo findings using both loss- and gain-of-function genetic assays that deletion of N-terminal 
residues consistently reduces DRaf’s signal potential in the Torso pathway. When expressed 
at high levels, FL DRaf enhanced the gain-of-function effects of the torRL3 allele much more 
significantly than DRaf$N114. In embryos from trk -/ - mothers, addition of FL DRaf, but not 
DRAF$N114, partially restored the A8 denticle belt structure (Figure II-4). These findings 
indicate that the N-terminus can play a positive role(s) in Torso RTK signaling. Interestingly, 
the contribution of DRaf’s N-terminus in the Torso pathway appeared to be dependent on 
upstream receptor activity, suggesting its role in transmission of the signal. Together with our 
yeast two-hybrid data, as well as the results obtained by Fischer et al. (2007) for BRaf, we 
propose that the presence of N-terminal residues may facilitate the association of DRaf with 
the upstream regulators Ras1 and Rap1, thereby assisting in transmission of the RTK signal 
in vivo.  
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For instance, in the trk - background, a small amount of active GTP-Ras1 and GTP-Rap1 
are likely present, mostly due to activation by residual upstream Trunk activity, the presence 
of Torso-like ligand, and/or the intrinsic activity of the Torso receptor. The trk1 mutation 
used in this analysis results in protein truncation at the last 16 amino acids. It is possible that 
over-expression of FL DRaf proteins in this background increases the likelihood of 
interaction between abundant DRaf proteins and membrane bound GTP-Ras1 or GTP-Rap1. 
This in turn, could elevate RTK signal and partially restore development of A8 posterior 
structures in some embryos. On the other hand, deletion of the N-terminus could destabilize 
Ras1-DRaf (or Rap1-DRaf) coupling or decrease the duration of interaction, resulting in 
reduced DRaf signal transmission. This may explain why expression of DRaf$N114 failed to 
rescue the A8 denticle belt in embryos from trk -/ - mothers. 
Why are only minor differences detected in vivo between FL DRaf and DRaf!N114: 
Previously, an auto-inhibitory role had been assigned to residues compromising the first half 
of the DRaf protein, in addition to their functions in promoting its activity. Deletion of the N-
terminal 1-272 (including the N-terminus and CR1) or 1-402 (including the N-terminus, CR1 
and CR2) of DRaf at least partially relieved these negative effects (BAEK et al. 1996). Here, 
although removal of the N-terminal 1-114 residues did not result in constitutive DRaf$N114 
activity in embryos lacking the maternal Torso receptor (Table II-1), it is still possible that 
the N-terminus may contribute to auto-inhibitory effects. Together with CR1 and CR2, these 
N-terminal residues (1-114) may help maintain DRaf’s inactive conformation. If so, the N-
terminus might play dual roles, both positively and negatively regulating DRaf. Therefore, its 
contribution to signaling may be neutralized by this auto-inhibition and consequently result 
in a subtle in vivo effect. If so, selective mutagenesis of the “inhibitory” motifs/sites in the N-
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terminal region or removal of other co-factors involved in its negative regulation may 
amplify signaling differences between FL DRaf and DRaf$N114.          
Ras binding has been thought crucial to recruit Raf to the plasma membrane and 
promote its RTK signaling activity. However, the Drosophila Torso pathway appears tolerant 
of alterations in Ras1-DRaf coupling (HOU et al. 1995). Draf C110 has a R174L point 
mutation in the RBD domain and likely comprised for Ras1 binding (LI et al. 1998). The 
RBDR174L is Ras binding-deficient in our yeast two-hybrid assay (Figure II-6B). However, tll 
expression patterns and cuticles of the embryos derived from mothers with Draf C110/Draf C110 
germ cells were indistinguishable from those of wild type embryos (MELNICK et al. 1993), 
suggesting a mechanism(s) independent of RBD-Ras1 interaction might function in 
recruiting DRaf to the plasma membrane. In agreement with this model, Rizzo et al. (2000) 
found membrane translocation of CRaf could be mediated by its interaction with 
phosphatidic acid (PA), and independent of Ras binding. This PA binding site is also 
conserved in ARaf, BRaf, and DRaf. Thus, DrafC110 could be recruited to the cell surface by 
associating with PA. Moreover, it is known that Raf’s CRD participates in Ras binding 
through its interaction with the lipid moiety of Ras (WILLIAMS et al. 2000; THAPAR et al. 
2004). Once at the membrane, it is also possible that the interaction between DrafC110’s CRD 
and Ras1 could further promote its membrane attachment and result in relatively normal 
Torso signal production. In this study, the presence of RBD, CRD and the potential PA 
binding site may be sufficient to promote DRaf’s activation in Torso signaling. This may 
explain why at ~ endogenous wild type protein level maternally expressed DRaf$N114 is able 
to rescue the embryonic terminal defects of Draf11-29 mutants (Figure II-1B, C and E). 
Together, considering the Torso pathway’s tolerance of alterations in Ras1-DRaf coupling 
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and the minor role DRaf’s N-terminus plays in Ras1 binding, it is reasonable that the 
phenotypic consequences of removing these N-terminal residues (DRaf$N114) are not great in 
Torso signaling.        
The subtle phenotypic effects of DRaf’s N-terminus could also be due to compensation 
provided by potential autoregulatory feedback or alternative redundant processes in the in 
vivo system. In our study, the expression of DRaf proteins at a low level (~1/4 endogenous 
wild type level) appeared to sensitize the assay system. We found deletion of the N-terminus 
seemed to increase the threshold of DRaf protein levels required for normal signaling. 
Furthermore, by adding one copy of the ectopic torRL3 allele or removing wild type maternal 
Trunk activity we apparently increased the sensitivity of the Torso pathway. These allowed 
the embryonic terminal system to display enhanced differences between FL DRaf and 
DRaf$N114 proteins. 
The biological implications of the N-terminal region: Why is this N-terminus with its 
“subtle” functional effects conserved during evolution, and what is its biological relevance? 
There are numerous RTK pathways functioning in Drosophila cellular and developmental 
processes. In spite of the identical Ras-Raf-MEK signal cassette they share, these RTK 
pathways can lead to different biological responses.  Previous studies indicated that such 
specificity might be due to the difference in the intensity and/or duration of the signal 
(GHIGLIONE et al. 1999; KERKHOFF and RAPP 1998; WOODS et al. 1997; WOODS et al. 
2001). This suggested that the magnitude of Raf signal could function as a critical 
determinant of biological responses.  Participation of multiple DRaf elements in Ras1 or 
Rap1 binding could be a good strategy to modulate its activity. Normally, tight association 
with Ras1 or Rap1 through RBD and CRD regions is required and sufficient to initiate the 
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activation of DRaf, while minor adjustments/regulation of interaction by the CRN region 
could optimize signaling potential and reduce variability. Thus, the extended N-terminus 
including CRN may play a role(s) as one element in a multi-domain effort to promote DRaf’s 
interaction with Ras1 and Rap1, participating and assisting in regulation to reliably attain 
maximal signal output.   
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Tables 
 
TABLE 1. Expression of FL DRaf or DRaf!N114 did not result in rescue of the A8 
dentical belt in embryos produced by torXR1/torXR1 females  
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Figure Legends 
Figure II-1. Rescue of posterior structures in embryos derived from Draf -/ - female 
germ cells by expression of full-length DRaf or truncated DRaf !N114 transgenes. (A) 
Schematic representations of full-length DRaf (FL DRaf) with 739 amino acids and truncated 
DRaf$N114 proteins. In addition to the 3 conserved regions (CR1, CR2 and CR3), FL DRaf 
has an extended N-terminus. (B) Western analysis of embryonic DRaf proteins from eggs 
produced by Draf 11-29/Draf 11-29 (Draf -/ -), wild type (WT), Draf -/ -; DRaf !N114 (3 
independent lines, L1 with ~1X endogenous DRaf level, #a and #b with ~1/4 endogenous 
DRaf level) and Draf -/ -; FL DRaf (2 independent lines, #a and #b with ~1/4 endogenous 
DRaf level) germline clone bearing females. Lysate was prepared from eggs at 0-3 hours 
after egg deposition. Full-length DRaf (~90 KD) and DRaf$N114 (~77 KD) proteins are 
denoted by arrows. Lysate of eggs from Draf -/ - germ cells was used as a negative control. !-
tubulin (!-tub) was used as the loading control. (C) A bar graph representing relative levels 
of DRaf proteins normalized with !-tubulin.  (D) Cuticles of mature embryos derived from 
wild type (WT), Draf -/ -, Draf -/ -; DRaf !N114 and Draf -/ -; FL DRaf female germ cells are 
shown in left panels. Accumulation of tll mRNA in cellular blastoderm embryos was 
detected by in situ hybridization (Right panels). Posterior tll expression is solely dependent 
on the Torso pathway and used as a marker for Torso RTK signaling. Anterior expression of 
tll is regulated by another pathway(s) in addition to Torso signaling, is more complex, and is 
used as an internal control for staining here. Wild type embryos show (i) normal Filzkörper 
structure (arrow), (i’) tll mRNA accumulation at the posterior (approximately 0-15% embryo 
length, EL), and an anterior head “stripe” (~75-85% EL). Embryos derived from Draf -/ - 
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germ cells lack (ii) posterior structures (A8 denticle belt, Filzkörper) and (ii’) posterior tll 
mRNA expression. (iii) An embryonic cuticle derived from Draf -/ -; DRaf !N114 germ cell 
lacks the Filzkörper structure.  (iii’) A reduced posterior tll expression domain is at ~0-8% 
EL in an embryo from Draf -/ -; DRaf !N114 germline clone bearing mother. (iv) Filzkörper 
structure (arrow) and (iv’) normal expression pattern of tll mRNAs are rescued by FL DRaf 
expression for embryos derived from Draf  -/ -; FL DRaf maternal germ cells. (E) A bar graph 
showing the percentage of embryos without Filzkörper (Fk) structures. When expressed at 
low maternal level (~1/4 endogenous level), embryos without Fk were found more often for 
those that inherited truncate Draf$N114 rather than full length DRaf proteins (&2=9.91976318, 
P<0.01).     
Figure II-2. Verification of DRaf protein quantitation assays and stability of DRaf 
proteins in early embryos. (A) Three samples representing lystes of 6, 12, and 18 eggs for 
each line (Draf  -/ -; DRaf !N114#a and Draf  -/ -; FL DRaf #a) were loaded for western blot 
analysis. Full-length DRaf (~90 KD) and DRaf$N114 (~77 KD) proteins are denoted by arrows. 
Lysate of eggs from Draf 11-29/Draf 11-29 (Draf -/ -)germ cells was used as a negative control. !-
tubulin levels were probed as a loading control. (B) Bar graph showing relative intensity of 
DRaf (dark bar) and !-tubulin (gray bar) bands. (C) A bar graph depicting normalized DRaf 
protein level from (A). (D) Western analysis of embryonic DRaf proteins from eggs collected 
at 0-1, 1-2 and 2-3 hours after deposition and produced by Draf -/ -,  Draf -/ -; DRaf !N114 (line 
#a) and Draf -/ -; FL DRaf (line #a) germline-bearing females. Full-length DRaf (~90 KD) 
and DRaf$N114 (~77 KD) proteins are denoted by arrows. !-tubulin was used as the loading 
control. (E) Normalized DRaf protein level from (D) is shown in this bar graph depicting the 
stable accumulation of these DRaf proteins. 
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Figure II-3. Gain-of-function effects of torRL3 are differentially enhanced by 
expression of FL DRaf and DRaf !N114 transgenes. (A) Western analysis of embryonic 
DRaf proteins from eggs (0-3 hours) produced by torRL3/+,  torRL3/+; DRaf !N114 (3 
independent lines, #1, #2, #3), or torRL3/+;FL DRaf (3 independent lines, #1, #2, #3) females 
at 29!. Full-length DRaf (~90 KD) and DRaf$N114 (~77 KD) proteins are denoted by arrows. 
!-tubulin was used as the loading control. (B) Normalized DRaf protein level from (A) is 
shown as a bar graph. (C) Cuticles of mature embryos are shown. (i) A wild type (WT) 
embryo exhibits normal cuticle pattern with 8 abdominal denticle belts. (ii) An embryonic 
cuticle derived from torRL3/+; FL DRaf mother has one broken abdominal denticle band 
(arrow head), and is missing one central abdominal denticle belt (arrow). (D) Percent of 
embryonic cuticles with gain-of-function phenotypes is shown in this bar graph. Gain-of-
function effects of torRL3 were differentially enhanced by FL DRaf and DRaf$N114 proteins 
(&2=51.063837, P<0.001). (E) Expression of engrailed (en) at ~stage 11 (Left panels) and 
accumulation of tailless (tll) mRNA at cellular blastoderm stage (Right panels) in embryos 
from WT, torRL3/+, torRL3/+;DRaf !N114, or torRL3/+;FL DRaf mothers: Examples of embryos 
derived from (i) WT, (ii) torRL3/+, and (iii) torRL3/+;DRaf !N114  mothers exhibit normal en 
mRNA pattern with 3 thoracic (T1-3) and 9 abdominal (A1-9) expression stripes. (iv) An 
embryo from torRL3/+; FL DRaf mother with partial deletion of en stripes (arrow) in a region 
that gives rise to central abdominal segmental pattern is shown. Examples of embryos 
derived from (i’) WT and (ii) torRL3/+ mothers exhibiting a normal tll mRNA pattern. (iii’) 
An embryo from a torRL3/+; DRaf !N114 mother shows slightly expanded posterior expression 
domain of tll. (iv’) An embryo derived from torRL3/+;FL DRaf females exhibits expanded 
domain of tll expression for both anterior and posterior regions.    
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Figure II-4. Effects of FL DRaf and DRaf!N114 expression on posterior development 
in embryos derived from trk 1/trk 1  mothers.  (A) Western analysis of embryonic DRaf 
proteins from eggs (0-3 hours) produced by Draf 11-29/Draf 11-29 (Draf -/- ), wild type (WT), trk 
1/trk 1 (trk -/ -), trk -/ -; DRaf !N114/DRaf !N114 (3 lines, #1/#3, #2/#2, #3/#3) and trk-/-; FL 
DRaf/FL DRaf (3 lines, #1/#1, #2/#2, #3/#3) females. Full-length DRaf (~90 KD) and 
DRaf$N114 (~77 KD) proteins are denoted by arrows. Embryonic lysate from Draf -/ - germline 
clone females was used as a negative control. !-tubulin was used as the loading control. (B) 
Normalized DRaf protein level from (A) is shown in the bar graph. (C) Representative 
cuticles of mature embryos derived from wild type (WT), trk -/ -, trk-/ -; DRaf !N114/DRaf !N114,  
or trk -/ -; FL DRaf/FL DRaf  females are shown (Left panels). Accumulation of en (Middle 
panels) and tll (Right panels) mRNAs were detected by in situ hybridization. (i) A wild type 
(WT) embryo has normal cuticle pattern with 8 abdominal denticle belts and Filzkörper 
structure. (i’) A WT embryo at gastrula stage has 3 thoracic (T1-3) and 9 abdominal (A1-9) 
en stripes. (i’’) A WT embryo at cellular blastoderm stage exhibits a normal posterior 
expression domain of tll.   (ii) Cuticle of a mature embryo from a trk -/- mother is missing 
posterior structures (A8 segment, Filzkörper). (ii’) A gastrulae embryo from a trk -/ - mother 
has abnormal en expression pattern with only 7 abdominal stripes. (ii’’) A cellular blastoderm 
embryo from a trk -/ - mother lacks posterior tll expression.  (iii) An embryonic cuticle from a 
trk -/-; DRaf !N114/DRaf !N114 mother lacks posterior structures (A8 denticle belt, Filzkörper). 
(ii’) A gastrula embryo from a trk -/ -; DRaf !N114/DRaf !N114 mother has only 7 abdominal en 
stripes. (ii’’) A cellular blastoderm embryo from a trk -/ -; DRaf !N114/DRaf !N114 mother lacks 
posterior expression of tll mRNA. Expression of FL DRaf (iv) restores the A8 denticle belt 
(arrow), (iv’) partially rescues the en mRNA pattern (8 abdominal stripes), and (iv’’) 
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posterior tll expression (arrow) in embryos lacking maternal Trk activity. (D) Effect of FL 
DRaf or DRaf !N114 transgene expression on A8 denticle development in embryos derived 
from trk -/ - mothers (percent of embryonic cuticles with A8 denticle belt). Shown are results 
using transgenic DRaf !N114 or FL DRaf lines that express DRaf protein at similar levels. 
Expression of exogenous FL DRaf, but not DRaf$N114, results in partial rescue of A8 denticle 
belt in some embryos derived from trk -/ - mothers (&2=82.8574882, P<0.001). 
Figure II-5. The N-terminus of DRaf contains a novel conserved region and has a 
high content of helical secondary structure. (A) Drosophila Raf (NP_525047; 739 amino 
acids) has in addition to its three conserved regions (CR1-3), an extensive N-terminus. A 
novel region (amino acids 19-77) within the N-terminus is conserved in honeybee Raf (A. 
mellifera XP_396892); frog BRaf (X. laevis AAU29410); chicken C-Rmil (G. gallus 
CAA47436); human BRaf (H. sapiens NP_004324); zebrafish BRaf (D. rerio BAD16728), 
sea urchin BRaf (S. purpuratus XP_781094), and termed Conserved Region N-terminal 
(CRN). Sequences of CRN were aligned using ClustalW (identities were denoted as “*”, 
strong and weak similarities were denoted as “:” and “.”, respectively in consensus line, 
http://www.ebi.ac.uk/tools/clustalw/), and the conserved residues were shaded using 
BOXSHADE (identities in black, similarities in gray, 
http://www.ch.embnet.org/software/box.form.html). Secondary structure prediction with 
GORV indicates CRN has the propensity to form two !-helices (!1 and !2). The putative 
PKC phosphorylation site DRaf’s Thr60 is framed. (B) Circular dichroism (CD) spectral 
measurement of DRaf’s N-terminus (amino acids 1-117) in vitro: The bilobed spectrum 
(arrows, local minima at ~209.4 nm and at ~221.4 nm) indicative of helical secondary 
structure is shown.  
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Figure II-6. Effects of the extended N-terminus of DRaf on Ras1 and Rap1 binding. 
(A) Schematic representations of different DRaf constructs used for yeast two-hybrid 
analysis. (B) Interactions between DRaf’s RBDs and Ras1$CAAX: Removal of CRN or the 
entire N-terminal region reduces Ras1$CAAX binding (P<0.05, t test). (C) Interactions 
between DRaf’s RBDs and Rap1$CAAX: Removal of CRN or the entire N-terminal region 
reduces Rap1$CAAX binding (P<0.05, t test). 
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Abstract 
The gene encoding Arl1 was originally cloned from Drosophila. Studies on this small 
GTPase have mainly focused on mammalian and yeast Arl1 proteins and mostly were 
conducted in cultured cells or in vitro. Although it has been demonstrated that Arl1 can 
recruit a set of golgins to golgi through interaction with the GRIP domain and functions in 
endosome-to-TGN (trans- Golgi Network) trafficking, the roles Arl1 plays in the 
development of multi-cellular organisms are not well defined. In this study, we describe our 
strategies to characterize the function(s) of Arl1 in the developmentally tractable system of 
Drosophila. We found, like its homologues in mammals and yeast, epitope-tagged fly Arl1 
was colocalized with Golgi markers both in vitro and in vivo. We analyzed three different 
arl1 mutants in Drosophila, and found that Arl1 is limitedly required during embryogenesis, 
although its mRNA accumulates ubiquitously in embryos. Most homozygous mutants of Arl1 
died during larval-pupa stage, however, we did not detect specific phenotypes associated 
with lethality. Ubiquitous expression of constitutively active arl1Q70L-mCherry reduced 
viability of flies, but did not affect development of the eye, wing, leg or bristles. 
Accumulation of arl1Q70L-mCherry  in nurse cells resulted in delay of border cell migration, 
suggesting that Arl1 may function in cellular morphogenetic movements.  
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Introduction 
The small GTPase ADP-ribosylation factor-like (Arf-like, Arl) proteins have high 
sequence similarity with Arfs. Among all Arl family members, Arl1 (Arf-like 1) is the closest 
relative to the Arfs (BURD et al. 2004). In spite of some properties similar to ARF proteins, 
such as the ability to bind and hydrolyze GTP, Arl1 was found completely devoid of ADP 
ribosylation activity, suggesting Arl1 is not a functional homolog of ARF (TAMKUN et al. 
1991). 
        The gene encoding Arf-like 1 (Arl1), was first cloned from Drosophila (Arf72A). It 
appears essential for normal development of flies (TAMKUN et al., 1991). Subsequently, Arl1 
was identified in mammals and yeast, exhibiting 60~80% amino acid sequence identity with 
Drosophila Arl1 (SCHURMANN et al., 1994; LEE et al., 1997).  
        Like other G proteins, Arl1 has two guanine nucleotide binding forms, GTP-Arl1 and 
GDP-Arl1. The GTP-bound Arl1 is active, while GDP-Arl1 is inactive. In mammals and 
yeast, active Arl1 is associated with the trans- side of Golgi. It seems that association of Arl1 
with Golgi is saturable and requires N-terminal glycine myristoylation. A mutant of Arl1 
lacking the myristoylation motif (arl1G2A, Gly2 Ala2) was absent from the Golgi (L! OWE et 
al. 1996; LEE et al. 1997; LU et al. 2001). 
       Active Arl1 can recruit a subset of golgins (Golgin-97, Golgin-245, Imp1p, etc.) onto 
Golgi membranes. These golgins have been suggested to function in maintaining the 
structure of the trans- Golgi network (TGN) and play a role(s) in endosome-to-TGN traffic 
(WU et al. 2003; LU et al. 2004; YOSHINO et al. 2005). The active Arl1 binding site has been 
mapped into the specific coiled-coil GRIP domains at the C-terminus of these golgins. 
However, interaction between Arl1 and some of its putative effectors are still controversial. 
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Burguete et al. (2007) found that both Arl1 and another golgi localized small GTPase, Rab6, 
bound to the C-terminus of golgin GCC185 in vitro and may cooperate in recruitment of 
GCC185 to Golgi membrane. While in the study by Houghton et al. (2009), the interaction 
between Rab6 or Arl1 and GCC185 was not detected, and localization of GCC185 appeared 
to be independent of Rab6 and Arl1 in culture cells.  
In CHO cells, exogenous expression of the GTPase-defective and constitutive active 
mutant arl1Q71L causes expansion of Golgi. While over-expression of arl1T31N, the dominant 
negative nucleotide exchange defective mutant of Arl1, leads to disassembly of Golgi 
apparatus (LU et al. 2001). Using a different approach, depletion of Arl1 by RNAi results in 
redistribution of specific TGN golgins including Goglin245, Golgin97 as well as SNARE 
proteins Vti1a and syntaxin 6 and 16, suggesting it functions in maintaining Golgi structures 
and intracellular traffic (NISHIMOTO-MORITA et al. 2009).  
       Overexpression of the GRIP region of golgin97, which is an effector of Arl1, abolished 
transport of E-cadherin from TGN to plasma membrane in Hela cells (LOCK et al. 2005). 
However, knockdown of Arl1 by RNAi did not change E-cadherin traffic (ZAHN et al. 2008). 
Although Arl1 was reported to regulate retrogade transport of Shiga toxin to TGN in cultured 
cells, no specific endogenous cargo was found for Arl1-mediated trafficking machinery so 
far. 
In Drosophila, Eisman et al. (2006) identified a GRIP-domain containing protein, 
centrosomin’s beautiful sister (Cbs, CG4840), which might be the homolog of mammalian 
Golgin-97 based on their sequence similarity. This Cbs protein functions in the centrosome 
cycle during mitosis potentially in an Arl1-dependent manner in Drosophila embryos and 
may be a putative effector of Arl1. However, the role Arl1 plays in regulating Cbs, and how 
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Arl1 functions in development of the multi-cellular organism remains elusive. 
        In a genome-wide RNAi assay performed by Friedman and Perrimon (2006) on 
Drosophila S2 cells, Arl1 was found among the candidates, which could be involved in the 
Ras-Raf-MEK RTK signaling. However, such information from high-throughput screen 
needs to be confirmed by further analysis and validated in vivo. 
        In this study, genetic analysis of three different arl1 mutants suggested that Arl1 could 
function in cell morphogenesis. Although Arl1 was found to interact with DRaf’s CR2 region 
in our yeast two-hybrid assay, it seemed that Arl1 mutations did not alter DRaf signaling. 
While an essential gene, Arl1 plays limited roles during Drosophila embryogenesis likely due 
to its functional redundancy with other genes. We also propose potential strategies, which 
may be helpful for further characterization of Arl1’s function.     
 
Materials and Methods 
Fly stocks: In this study, Oregon R, arl14107(Bloomington Stock Center, #4107 ), 
arl19.2BC, arl11 (obtained from Dr. Jim Kennison) lines were used. The “FLP-DFS” technique 
was utilized to generate arl19.2BC and arl14107 germline clones (CHOU and PERRIMON 1996). 
Drosophila stocks were raised at 25! on standard cornmeal medium.  
Molecular Characterization of Mutations: DNAs from arl19.2BC /+ and arl14107/+ 
were used as templates for PCR reactions with primers P1-Forward (5’ GCGCCA 
GCACTAGACAAAG 3’) and P1-Reverse (5’GAAATAGCACGAATTGAGATTAG 3’) 
that compass the open reading frame (ORF) of the Arl1 gene. PCR products were cloned to 
the pGEM-T vector. For each allele, 10 colonies were picked up and  sequenced.     
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DNA constructs: The YFP-Golgi construct was kindly provided by Dr. Cungui Mao. 
T30N and Q70L mutations in Arl1 were generated by PCR-based site-directed mutagenesis 
and confirmed by sequencing. EGFP-tagged Arl1s were constructed by inserting DNA 
encoding Arl1 or $17arl1 into the pEGFP-N1 vectors (Clontech). The coding sequence for 
Myc or mCherry epitopes were fused to the C-termius of arl1 cDNA inserted into the pMT 
vector to generate Arl1-Myc or Arl1-mCherry constructs.  
Transgenic design: DNA encoding mCherry-tagged wild type Arl1 was cloned into the 
polylinker site of the P-element transformation vector pCaSpeR-HS83. The constitutively 
active heat-shock 83 gene promoter was used to drive the expression of wild type Arl1-
mCherry. The arl1Q70L-mCherry cDNA was cloned into the pUASp vector and used to 
generate the UASp-arl1Q70L-mCherry construct. The UASp promoter allows spatio-
temporal expression when combined with different Drosophila Gal4 drivers. Transgenic lines 
were generated by P-element-mediated transformation.  
Transfection in S2 cells: Drosophila S2 cells (obtained from Drosophila Genomics 
Research Center) were grown in Schneider’s medium (Cambrex) supplemented with 10% 
fetal bovine serum (Invitrogen) at 25 °C. The cultured cells were transfected using CaPi 
transfection kit according to the standard protocol (Invitrogen). Cells transfected with pMT 
construncts were treated with 50ug/ml CuSO4, 14 hours after transfection to induce the MT 
(Metallothionein) promoter. 
Immunostaining: Embryos and ovaries were fixed in 4% paraformaldehyde in 
phosphate buffered saline (PBS, pH7.4) and immunostained with antibodies using standard 
protocols. Hoechst was used to stain DNA. Mouse-anti-FasIII (1:1000) and Rat-anti-E-Cad 
(1:200) were obtained from Developmental Studies Hybridoma Bank (Iowa City), and 
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Rabbit-anti-GFP (1:1000) was from (Torrey Pines Biolabs).  Secondary antibodies 
conjugated with Alexa Fluor were obtained from Molecular Probes.  
In situ hybrizidation: arl1 probes were generated from wild type cDNA clones 
(NM_079374) using the PCR DIG probe synthesis kit (Roche Applied Science). Whole-
mount mRNA in situ hybridizations were performed in embryos according to the protocol of 
Tautz and Pfeifle (1989) with minor modifications. 
        Yeast two-hybrid: Cbs (NM_137031) cDNA was obtained from the Drosophila 
Genomics Research Center. DNA sequences corresponding to DRafCR2, $17Arl1, 
$17Arl1T30N, $17Arl1Q70L, and CbsGRIP proteins were cloned into pGADT7 or pGBKT7 
vectors (Clontech). These recombinant constructs in pGADT7 and pGBKT7 plasmids were 
transformed into yeast Y187 strain according to standard protocol (Clontech). Protein-protein 
interactions were tested by ß-Galactosidase assays using X-gal (5-bromo-4-chloro-3-indolyl-
b-D-galactopyranoside, Sigma; solid-support assay) as substrates. All yeast two-hybrid 
experiments are confirmed by reciprocal bait-prey assays and repeated at least 4 times. 
 
Results 
Interaction between Arl1 and DRaf’s CR2 region: In our yeast two-hybrid screen 
using the CR2 region of DRaf as the bait, we obtained a positive colony and subsequently  
the plasmid Drosophila insert was identified as the small GTPase Arl1 (Table III-1). The 
interaction between Arl1 and CR2 was confirmed by reciprocal bait-prey assays, suggesting 
Arl1 may be a binding partner of DRaf and play a role(s) in Raf signaling.  
        Generation and identification of arl1 alleles: We initiated our study on Arl1 using a 
classic genetic strategy to characterize Arl1 phenotypes in arl1- mutant animals. A recessive 
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lethal arl1 mutation was recovered by Tamkun et al. (1991), and it was used to demonstrate 
that arl1 is an essential gene. We obtained one loss-of-function allele of arl1, arl14107, from 
the Bloomington Drosophila stock center (#4107). Generation of an additional loss-of-
function allele and phenotypic analysis of these different arl1 alleles is  the strategy we used 
to characterize Arl1’s function in Drosophila development. Using arl14107, we conducted a 
mutagenesis screen to identify non-complementing alleles of arl1 (See Appendix 1). In our 
screen (~3,000 chromosomes), we isolated one new allele arl19.2BC. When placed over a 
deficiency for the chromosomal region that covers arl1 gene [Df(3L)th102], both arl14107 and 
arl19.2BC exhibited non-complementation. Both arl14107/Df(3L)th102 and 
arl19.2BC/Df(3L)th102 were viable when in a background that contains a duplication for the 
arl1 gene (Table III-2). So, it was confirmed that both arl14107 and arl19.2BC are loss-of-
function alleles of arl1. However, neither arl14107/arl14107 nor arl19.2BC/arl19.2BC can be 
rescued by the wild type Arl1 transgene obtained from J. Kennison, indicating these two lines 
contained additional lethal mutations on the mutant arl1 chromosome. We sequenced the two 
arl1 alleles. The arl19.2BC mutation was likely a complete loss-of-function allele, as it was 
predicted to encode a truncated Arl1 protein of 36 amino acids (Figure III-1).  The equivalent 
change for mammalian Arl1 would eliminate the effector and all known protein interaction 
domains (WU et al. 2003).  The arl14107 mutation was predicted to encode a truncated Arl1 
protein of 165 amino acids, lacking the C-terminal 15 amino acids (Figure III-1), this region 
is known to form an "-helical ("5) structure in mammalian Arl1 (WU et al. 2003).  
Classical genetic analysis of Arl1 using arl1- mutants: Both arl14107 and arl19.2BC are 
recessive lethal mutations. We found most homozygous arl14107 or arl19.2BC mutants 
proceeded through embryogenesis and died during larval and pupal stages (Table III-3). 
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Cuticles of unhatched of arl1-/arl1- embryos appeared to be relatively normal with 1-2% 
showing head involution defects (HID) (Table III-4). All arl1-/arl1- larvae appeared normal 
in their exoskeletal pattern. Using a different allele, arf72A1 (arl11), Eisman et al. (2006) 
reported that loss of Arl1 function led to mitotic defects and embryonic lethality. 
Subsequently, we requested and obtained the arl11 line from the Kennison’s group, who 
originally isolated the arl11 allele. Like arl14107 or arl19.2BC alleles, arl11 is recessive lethal. 
However, most eggs homozygous for the arl11 mutation hatched as larva. Embryonic cuticles 
of homozygous arl11 mutants appeared relatively normal (Table III-3, Table III-4). It seems 
that the arl11 chromosome also contains mutations in other genes, for arl11/Df(3L)th102, but 
not arl11/arl11 mutants, can be rescued by the wild type Arl1 transgene. Therefore, our 
genetics analysis using three independent alleles suggests that zygotic Arl1 may be not 
essential for the development of embryos.       
Next we generated females with arl19.2BC/arl19.2BC or arl14107/arl14107 germ cells to 
understand Arl1’s maternal role. Using the FLP-FRT system (CHOU and PERRIMON 1996), 
arl1-/arl1- germ line clones were produced and used to study early fly development in the 
absence of maternal Arl1 activity. When crossed with Oregon R (OR) wild type males, the 
arl1- containing germ line clone virgin females laid eggs, which are zygotically heterozygous 
for Arl1, but lacked maternal Arl1 activity. Some eggs derived from arl1-/arl1- germ cells did 
not hatch. Most embryonic cuticles of the unhatched eggs are phenotypically normal (Table 
III-5, Table III-6), and all have the posterior Filzkörper structure, and normal central 
abdominal development suggesting the Torso RTK-Ras-Raf signaling pathway is not 
affected by the arl1 mutation (Loss of Torso RTK signaling results in loss of the Filzkörper, 
while gain of pathway activity causes reduced segmentation in the central abdominal region). 
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About 70% of those unhatched eggs do not have cuticles and are likely unfertilized, since 
most embryos (0-15 hours after egg deposition), when stained with a nucleus marker and the 
FasIII antibody, appeared to be phenotypically normal with only a few showing head 
involution defects (Table III-6, 7; Figure III-2). The genetic cross with arl1-/+ males did not 
significantly alter the hatch rates of the eggs from the females with arl1-/arl1- germ lines 
(Table III-5), implying removal of paternal Arl1 in half of the eggs did not affect their 
embryogenesis. Therefore, our study suggests both maternal and zygotic Arl1 proteins play 
limited roles during embryogenesis.  
        In our genetic assays, head involution defects were observed for some embryos, 
although at low penetrance. Thereby, loss of Arl1 function may lead to abnormal cellular 
morphogenetic movements. The HID defect may not be relevant to Ras-Raf signaling, since 
we did not detect a genetic interaction, when the arl1-/arl1- germline-bearing females were 
crossed with ras1e2b/+ males (Table III-6). 
       The head involution defects observed could be due to the dysregulation of adhesion 
proteins (VANHOOK and LETSOU 2007). Adhesion molecules are thought to function in 
cellular morphogenesis through their dynamic presence on the cell surface, which can be 
regulated by endocytosis and exocytosis (EDELMAN 1985; GUMBINER 1996; SETO et al. 
2002). Considering Arl1’s potential roles in trafficking, we developed the hypothesis that 
Arl1 might participate in intracellular transport of adhesion proteins. If so, then in eggs from 
arl1-/arl1- germ cells when fertilized by males with a mutation in a gene that acts in adhesion, 
reduced viability is anticipated for transheterozygous individuals. We tested for genetic 
interaction of arl1 alleles with mutations in numerous genes encoding membrane-localized 
adhesion molecules. However, no additive or synergistic effects were seen (Table III-8, 9). 
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        Many coiled-coil golgin tethers, containing GRIP domains, have been identified as Arl1 
effectors. The Golgi localization of these golgins, likely mediated by the interactions between 
the GRIP domains and Arl1, appeared essential for their functions (LU et al. 2004). However, 
recently these golgins have been shown to associate with numerous additional small GTPase 
regulators. For instances, dGolgin97, dGolgin245 and dGCC185 contain multiple binding 
sites for the Rab family of G proteins (SINKA et al. 2008). Therefore, Arl1 may act, together 
with these Rab proteins, to mediate the function of downstream golgins. This implies a 
degree of redundancy between the Arl1 and Rabs, which could explain only mild phenotypes 
observed in arl1 mutants upon removal of normal Arl1 activity. However, no genetic 
interaction, with the limited number of candidates (Rab6, Rab11 etc.) that we tested, was 
detected (Table III-10, 11). Therefore, there might be other proteins that function redundantly 
with Arl1. Together, our analysis implies that it is difficult to dissect Arl1’s roles using 
classical genetic methods to study these arl1 alleles. 
        An over-expression strategy to characterize Arl1’s function in Drosophila: One 
strategy for characterizing a gene’s functions is to study the effects of overexpressing its 
mutant products. In mammalian cultured cells, over-expression of constitutive active arl1Q71L 
abolishes traffic of VSVG and Shiga toxin (LU et al. 2001). We generated the mCherry-
tagged arl1Q70L with an equivalent point mutation. The arl1Q70L-mCherry cDNA was cloned 
into pUASp vector and used to generate UASp-arl1Q70L-mCherry transgenic flies. The UASp 
promoter allows spatio-temporal expression when combined with different Drosophila Gal4 
drivers in somatic and germ-line cells (RORTH 1998). We also generated the wild type Arl1-
mCherry lines as the control. The constitutively active heat-shock 83 (HS83) promoter was 
selected to drive the ubiquitous expression of mCherry-tagged Arl1 protein (pCaspeR-HS83-
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Arl1-mCherry). Overexpression of Arl1-mCherry did not affect the viability of the flies, and 
the Arl-mCherry transgene rescued the lethality of arl14107/Df(3L)th102 and 
arl19.2BC/Df(3L)th102 flies, suggesting mCherry-tagged Arl1 is capable of replacing the 
endogenous gene.  
         We found ubiquitous expression of arl1Q70L-mCherry driven by actin-Gal4 or tubulin-
Gal4 decreased the viability of flies. However, development of eyes, wings, legs and thoracic 
bristles of surviving adults appeared phenotypically normal. Considering the potential roles 
of Arl1 in traffic, we also tried to over-express arl1Q70L-mCherry using the salivary gland-
Gal4 (SG-Gal4) driver to see if it affects secretion of glue proteins and/or the morphology of 
salivary gland cells. However, we did not detect any defects for SG-Gal4/+; arl1Q70L-
mCherry larva and their salivary glands appeared normal when stained with E-cadherin and a 
nuclear marker. All the these larvae stick to the vial wall and form pupa as well as wild type, 
suggesting secretion of glue proteins was relatively normal.  
         Expression of arl1Q70L-mCherry in ovaries: During oogenesis, border cells migrate 
between nurse cells to the anterior end of oocyte. Cell surface-localized adhesion molecules 
mediate the border-nurse cell contacts required for this process.  Their localization on plasma 
membranes can be regulated dynamically by exocytosis and endocytosis, so that rounds of 
binding and release allow the border cells to move between the nurse cells (MONTELL 2003; 
BRYANT and STOW 2004). Dysregulation of the dynamic presence of adhesion proteins on 
the cell surface could result in border cell migration defects, which subsequently leads to a 
failure of micropyle structure formation and female sterility. We found over-expression of 
arl1Q70L-mCherry in germ cells driven by nanos-Gal4 reduced female fertility and ~8% of 
stage 10 egg chambers of these females exhibited a delay in border cell migration (Figure III-
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3, Table III-12). We did not detect such migration defects upon expression of arl1Q70L-
mCherry driven by slbo-Gal4 in border cells. Considering Arl1’s potential functions in 
intracellular transport, we propose that the border cell migration defects upon over-
expression of arl1Q70L-mCherry might be due to dysregulation of adhesion molecules in nurse 
cells. However, none of the mutations in adhesion molecules we tested showed additive or 
synergistic effects when arl1Q70L-mCherry was over-expressed in germ cells (Table III-13).  
Accumulation of Arl1 mRNA in Drosophila embryos: The spatio-temporal 
expression pattern of a gene sometimes exhibits correlation with its function(s).   A study of 
the Arl1 mRNA accumulation pattern in embryos may provide some clues about its 
biological roles. We performed whole mount in situ hybridization to explore when and in 
which cells the Arl1 gene is transcribed during embryogenesis. We found Arl1 mRNA was 
ubiquitously distributed in embryos with a higher level in certain tissues. Arl1 mRNAs were 
enriched underneath the cortical layer of stage 5 embryos. At later stages (stage 6-10), 
abundant Arl1 mRNAs were detected in the ventral, cephalic, anterior and posterior 
transversal furrows. After completion of gastulation, Arl mRNAs were enriched in brain 
lobes and central nerve system (Figure III-4).    
Epitope-tagged Arl1 is colocalized with Golgi marker: In yeast and mammalian 
cultured cells, Arl1 was found localized in Golgi membrane (LOWE et al. 1996; LEE et al. 
1997; LU et al. 2001). To study the subcellular localization of Arl1, Drosophila S2 cells 
expressing different epitope-tagged (mCherry, Myc and EGFP) Arl1 proteins were co-
transfected with YFP-tagged Golgi marker (YFP-Golgi, containing the N-terminal 1-81 
region of human ß 1,4-galactosyltransferase, which is a trans- Golgi protein) or stained with 
the Golgi marker TRITC-Ceramide (LAJEUNESSE et al. 2004). All these epitope-tagged Arl1 
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proteins exhibit a punctuate pattern and show nice colocalization with Golgi markers (Figure 
III-5). Arl1’s localization in vivo was also tested using the Arl1-mCherry transgenic lines. 
We dissected the ovaries from females YFP-Golgi/Arl1-mCherry and found Arl1-mCherry is 
colocalized with the Golgi marker in oocytes. Consistently, Arl1-mCherry also showed a 
pattern of colocalization with YFP-Golgi in brain cells from the 3rd instar larva of the 
transgenic lines (Figure III-6). 
In mammals, the N-term 1-17 region is very likely to form an amphipathic helix and 
contains a glycine site  (G2), which can be myristoylated. The glycine myristoylation and 
probably the amphipathic helix structure, are important for targeting Arl1 to Golgi 
membranes (LU et al., 2001; WU et al., 2003). Deletion of the N1-17 region or mutation at 
G2 results in loss of golgi localization. In our study, when the N-terminal 1-17 region was 
removed ($17arl1-EGFP), Arl1 lost its fragmented pattern and instead was dispersed in the 
cytoplasm (Figure III-5B). These findings in Drosophila are consistent with those in yeast 
and mammals. 
Interaction between Arl1 and GRIP: Previously, Eisman et al. (2006) identified a 
GRIP domain-containing protein, centrosomin’s beautiful sister (Cbs, CG4840). Cbs 
apprears to be the ortholog of golgin97, and is a putative effector of Arl1. We found that Arl1 
can associate with the GRIP region of Cbs in a GTP dependent manner in a yeast two-hybrid 
assay. The coiled-coil region (CC) preceding GRIP contains binding sites for small GTPase 
Rab proteins, however, we did not detect interaction between CC and Arl1 (Figure III-7). 
These are consistent with previous studies by others (SINKA et al. 2008).   
 73
Discussion 
Is Ar1l involved in DRaf signaling: In our yeast two-hybrid screen using the CR2 
region of DRaf as the bait, we identified the small GTPase Arl1 as a potential binding partner 
of DRaf. In yeast and mammalian cultured cells, the Golgi-localized Arl1 can  interact with 
the GRIP domain of coiled-coil golgin proteins, and is thought to function in intracellular 
transport (LOWE et al. 1996; LEE et al. 1997; LU et al. 2001; LU et al. 2004). Although 
mammalian Raf has been found associated with Golgi, this was attributed to Ras binding 
(CHIU et al. 2002). The interaction between Arl1 and Raf has not been described, and it is not 
clear if Arl1 is relevant to Raf signaling. 
Friedman and Perrimon (2006) performed a genome-wide RNAi assay in Drosophila S2 
cells to identify potential signal components of RTK pathways. In their primary screen, 
knock down of Arl1 seemed to increase the phosphorylation level of ERK, suggesting that 
Arl1 may have inhibitory effects on RTK signaling. However, such information from high-
throughput screen needs to be confirmed by further analysis. Particularly, genetic 
characterization of Arl1 in vivo is necessary for validation of its potential roles. 
        Previously, a golgi protein, RKTG, has been identified as a negative regulator of CRaf 
and BRaf in mammalian cells. Over-expression of RKTG can prevent Raf activation by 
recruiting cytoplasmic Raf to golgi and hidering its translocation to plasma membrane (FENG 
et al. 2007 ). If Arl1 functions in inhibiting the ERK signal, as suggested by Friedman and 
Perrimon’s study (2006), it is possible that it acts like RKTG to capture Raf on golgi 
membrane through its interaction with CR2, thus playing a negative role in Raf signaling.     
        We attempted to determine the function of this small GTPase Arl1 in Drosophila using 
classic genetic methods. However, we did not detect Raf-related phenotypical effects upon 
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mutation of Arl1, thus, it is still unclear whether Arl1 is relevant to ERK signal transduction 
in vivo.   
        Arl1 may function in cellular morphogenetic movements: Adhesion molecules, like 
cadherin proteins, play very important roles in epithelial morphogenesis, cell-cell 
communications, as well as cell migration. In order to fulfill these roles, these adhesion 
proteins must be delivered efficiently to the cell surface, where they are incorporated into 
protein complexes with other partners (EDELMAN 1985; GUMBINER 1996). During cell 
migration, their localization to the plasma membrane can be regulated dynamically by 
exocytosis and endocytosis (SETO et al. 2002; BRYANT and STOW 2004). Dysregulation of 
their dynamic presence on the cell surface could result in morphogenesis defects. In our 
study, over-expression of arl1Q70L-mCherry in germ cells resulted in a delay of border cell 
migration in some egg chambers. We also observed, though at low penetrance, head 
involution defects in embryos with Arl1 mutations. These suggest Arl1 may function in 
cellular morphogenetic movements. Considering Arl1’s golgi localization and its potential 
role in intracellular transport, it is possible that Arl1 may be involved in trafficking of 
adhesion molecules. For instance, loss of normal Arl1 function could inhibit the endocytosis 
of adhesion molecules in nurse cells. Therefore the constitutive presence of the “sticky” 
adhesion proteins on the cell surface would hider the movement of border cells and result in 
delay of their migration.    
Dynamic rearrangement of the cytoskeleton, including actin filaments, also contributes 
to cellular morphogenesis. Distorting the actin cytoskeleton in Drosophila embryos results in 
head involution/dorsal closure defects (ELISABETH and MULLER 1998). Previously, it has 
been reported that some small GTPases (Rac, Rho, etc.) can regulate the structure of the actin 
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cytoskeleton (SHARP et al. 2005). It is also possible that Arl1 could be involved in cellular 
morphogenetic movement, like these small G proteins, by regulating dynamic rearrangement 
of cytoskeleton.    
Challenges in genetic analysis of Arl1’s developmental roles: The Arl1 small GTPase 
is thought to regulate coiled-coil golgin proteins through interaction with their GRIP domains 
(LU et al. 2004). The golgins may act like tethers and provide the contact sites for other golgi 
cisternae, arriving cargo, and intracellular vesicles including endosomes, thereby function in 
golgi morphology and traffic. However, these golgins contain binding sites for other 
regulators, in addition to Arl1. Particularly, the Golgi-localized Rab small GTPases (Rab2, 
Rab6, Rab19, Rab30, Rab39, etc.) can interact with numerous coiled-coil golgin tethers and 
may function redundantly with Arl1 (SINKA et al. 2008). This may explain why loss of Arl1 
activity only resulted in mild phenotypes in Drosophila embryos. 
        In mammals, there are ~70 members of the Rab small GTPase family. These Rab 
proteins have been found localized in different intracellular organelles (ER, Golgi, early 
endosome, late endosome, recycling endosome, etc.) and function in membrane trafficking 
(STENMARK and OLKKONEN 2001).  In Drosophila, 33 Rab members with high sequence 
similarity have been identified (ZHANG et al. 2007). The golgin proteins contain multiple 
binding sites in their coiled-coil regions for numerous Rab proteins, which may include, 
besides those localized in Golgi, some associating with other intracellular vesicles. It is 
possible, as proposed by SINKA et al. (2008), that golgins may be anchored to the Golgi 
through interactions between their C-termini and Arl1 or Rab6 etc., while the remaining 
portions of these molecules may project into the cytoplasm like tentacles. Numerous coiled-
coil golgin proteins (Golgin97, Golgin245, etc.) share this structural feature with mutiple 
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binding sites for Rab members located along the tentacles (SINKA et al. 2008), so that they 
could act collectively by capturing arriving vesicles bearing Rabs (Rab4, Rab5, Rab9, or 
Rab11-bearing endosomes, etc.) to Golgi membranes. If so, the GRIP-containing golgin 
proteins, which are potential effectors of Arl1, could also function redundantly with each 
other.  This could explain why, in several recent studies, functional depletion of particular 
golgins did not lead to severe phenotypic defects (SINKA et al. 2008). Together, the potential 
functional redundancy for Arl1 as well as its effectors may confound our genetic analysis on 
Arl1.   
         Potential strategies for further characterization of Arl1’s role: Drosophila has been 
thought to be one of the best-understood multi-cellular model organisms. However, among 
more than 15,000 annotated genes in flies, most (~85%), when mutated, did not show 
detectable phenotypes. Lack of phenotypic information regarding these genes does not mean 
they don’t have significant functions, instead, it is likely that most of them play important 
roles but act redundantly with other genes (www.flyrnai.org/TriP-HOME.html). To resolve 
such an issue of functional redundancy, one could disrupt the activity of all/most of the 
redundant genes that play a role in a particular cellular process. NIH has just begun to 
support TRiP (Transgenic RNAi Project), a project to develop the UAS-RNAi system in a 
genome-wide scale. By combining RNAi sequences of several different genes (Arl1, Rab2, 
Rab6, etc.), we could simultaneously deplete their functions in flies. Particularly, based on 
their mRNA pattern in embryos, we could knock down these genes in specific tissues or at 
specific developmental stages using the Gal4-UAS system, and test their functional roles 
with a spatial and temporal resolution.  
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In our study, over-expression of arl1Q70L-mCherry in germ cells resulted in delay of 
border cell migration in some egg chambers. We also observed, though at low penetrance, 
head involution defects in embryos that lack maternal Arl1 activity. These findings suggest 
Arl1 may function in cellular morphogenetic movements. Considering Arl1’s golgi 
localization and its potential role in intracellular transport, we propose that Arl1 may be 
involved in trafficking of adhesion molecules, although we did not detect any additive or 
synergistic genetic interaction between Arl1 and numerous genes encoding adhesion proteins. 
Identification of the components/cargo of the Arl1 complex/traffic machinery using 
proteomic approaches could be a helpful approach to characterize its developmental roles. 
Particularly, one could co-precipitate or pull-down the proteins of Arl1 complexes from 
cellular lysates, and using mass spectrum analysis, identify components of the complex(es). 
This method may also validate Raf-Arl1 interaction in vivo. A combination of such 
proteomic approaches may allow the in vivo genetic analysis of Arl1 more promising.        
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Tables 
 
TABLE III-1. Interaction between Arl1 and the CR2 region of DRaf. 
Interact w/ N CR1 CR2 CR3 CR1CR2 NCR1CR2 FL DRaf 
Arl1 No No Yes No Yes Yes No 
 
 
 
 
 
TABLE III-2: Both arl14107 and arl19.2B alleles are loss of function alleles of arl1. 
 
Allele tested 
 
arl14107
 
arl19.2Bc
 
Df(3L)th102 
 
Df(3L)st-f13 
 
Df(3L)brm11 
Df(3L)th102; 
Dp(3;Y)L131-D3 
 
arl14107
 
L 
 
L 
 
L 
 
V 
 
L 
 
V = males 
 
arl19.2BC
 
L 
 
L 
 
L 
 
V 
 
L 
 
V = males 
L = no complementation, lethal; V = viable 
Bloomington #3641: Df(3L)th102, h[1] kni[ri-1] e[s]/TM6C, cu[1] Sb[1] ca[1] 
Breakpoints: 71F3-5;72D12 
Bloomington #2993: Df(3L)st-f13, Ki[1] rn[roe-1] p[p]/TM6B, Tb[1] 
Breakpoints:  72C1-D1;73A3-4 
Bloomington #3640: Df(3L)brm11/TM6C, cu[1] Sb[1] ca[1] 
Breakpoints: 71F1-4;72D1-10 
Bloomington #5462: Df(3L)th102, h[1] kni[ri-1] e[s]/TM6C, cu[1]Sb[1]ca[1]; Dp(3;Y)L131-D3, B[S] 
Breakpoints:  72A2;72D10, 72A;75D4-5;Y 
 
 
 
 
TABLE III-3. Most homozygous arl1 mutants proceeded through embryogenesis. 
Maternal Paternal #Hatched (%) #Unhatched* (%) Total 
arl19.2BC/+ arl19.2BC/+ 655 (75.1) 217 (24.9) 872 
arl19.2BC/+ +/+ 627 (87.1) 93 (12.9) 720 
arl14107/+ arl14107/+ 482 (79.8) 123 (20.2) 605 
arl14107/+ +/+ 355 (87.9) 49 (12.1) 404 
arl11/+ arl11/+ 201 (83.1) 41 (16.9) 242 
arl11/+ +/+ 177 (89.4) 22 (10.6) 198 
arl11/+ arl19.2BC/+ 213 (84.9) 38 (15.1) 251 
+/+ +/+ 347 (86.3) 55 (13.7) 402 
* Unhatched eggs comprise three classes: unfertilized eggs, embryos that develop poorly and do not make cuticles and 
embryos that produce cuticles but do not hatch.   
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TABLE III-4. Embryonic cuticles of arl1-/arl1- mutants are relatively normal. 
Non-GFP embryos  
Maternal 
 
Patermal 
#Normal (%) #HID *(%) 
 
Total 
arl19.2BC/GFP arl19.2BC/GFP 71 (98.6) 1 (1.4) 72 
arl14107/GFP arl14107/GFP 88 (98.8) 1 (1.2) 89 
arl11/GFP arl11/GFP 60 (100) 0 (0) 60 
arl19.2BC/arl19.2BC arl19.2BC/GFP 25 (92.6) 2 (7.4) 27 
* HID: Head involution defects 
 
 
 
TABLE III-5. Hatch rates of eggs from germline clone bearing females. 
Maternal Paternal #Hatched (%) #Unhatched * (%) Total 
arl19.2BC/arl19.2BC arl19.2BC/+ 203 (60.4) 133(39.6) 336 
arl19.2BC/arl19.2BC +/+ 456 (63.3) 264(36.7) 720 
arl14107/arl14107 arl14107/+ 287 (41.8) 400 (58.2) 687 
arl14107/arl14107 +/+ 372 (33.8) 728 (66.2) 1100 
FRT2A/FRT2A 
+/+ 146 (70.9) 60 (29.1) 206 
* Unhatched eggs comprise three classes: unfertilized eggs, embryos that develop poorly and do not make cuticles and 
embryos that produce cuticles but do not hatch. 
 
 
 
TABLE III-6. Some embryonic cuticles of unhatched eggs from germline clone bearing 
females have head involution defects or body hole. 
Maternal Paternal #Normal (%) #HID or BD* (%) #Total 
arl19.2BC/arl19.2BC +/+ 32 (94.1) 2 (5.9) 34 
arl19.2BC/arl19.2BC arl19.2BC/+ 29 (93.5) 2 (6.5) 31 
arl14107/arl14107 +/+ 31 (96.9) 1 (3.1) 32 
arl14107/arl14107 arl14107/+ 21 (95.5) 1 (4.5) 22 
arl19.2BC/arl19.2BC Rase2B/+ 25 (96.2) 1 (3.8) 26 
FRT2A/FRT2A +/+ 27 (100) 0 (0) 27 
*HID or BD: head involution defects or body hole 
 
 
 
TABLE III-7. Some embryonic from germline clone bearing females have head 
involution defcts (FasIII staining). 
Maternal #Normal(%)  #HID*(%) #Total 
arl19.2BC/arl19.2BC 71 (92.2) 6 (7.8) 77 
arl14107/arl14107 54 (94.7) 3 (5.3) 57 
FRT2A/FRT2A 34 (100) 0 (0) 34 
*HID: head involution defects 
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TABLE III-8. Genetic interaction tests between arl1 mutations and alleles of adhesion 
genes on the second chromosome (*Cyo: Balancer chromosome). 
Genetic cross #CyO * #Non-CyO  #Total 
+/+; arl19.2BC/arl19.2BC X + /CyO;+/+ 371 444 815 
+/+; arl14107/arl14107 X +/CyO;+/+ 146 179 325 
+/+; FRT2A/FRT2A  X  +/CyO;+/+ 320 364 684 
+/+; arl19.2BC/arl19.2BC X shg k03401/CyO;+/+ 169 125 294 
+/+; arl14107/arl14107 X shg k03401/CyO;+/+ 113 103 216 
+/+; FRT2A/FRT2A  X shg k03401/CyO;+/+ 95 89 184 
+/+; arl19.2BC/arl19.2BC X shgR69 /CyO;+/+ 222 204 426 
+/+; arl14107/arl14107 X shgR69 /CyO;+/+ 58 54 112 
+/+; FRT2A/FRT2A X shgR69 /CyO;+/+ 152 134 286 
+/+; arl19.2BC/arl19.2BC X dystroglycan- /CyO;+/+ 82 86 168 
+/+; arl14107/arl14107 X dystroglycan- /CyO;+/+ 28 37 65 
+/+; FRT2A/FRT2A  X dystroglycan- /CyO;+/+ 150 129 279 
+/+; arl19.2BC/arl19.2BC X dgB148 /CyO;+/+ 61 62 123 
+/+; arl14107/arl14107 X dgB148 /CyO;+/+ 37 43 80 
+/+; FRT2A/FRT2A X dgB148 /CyO;+/+ 26 32 58 
+/+; arl19.2BC/arl19.2BC X ftg-rv / CyO;+/+ 63 102 185 
+/+; arl14107/arl14107 X ftg-rv /CyO;+/+ 38 46 84 
+/+; FRT2A/FRT2A  X ftg-rv /CyO;+/+ 40 61 101 
+/+; arl19.2BC/arl19.2BC X stan192 /CyO;+/+ 63 73 136 
+/+; arl14107/arl14107 X stan192 /CyO;+/+ 77 79 156 
+/+; FRT2A/FRT2A  X stan192 /CyO;+/+ 56 64 120 
+/+; arl19.2BC/arl19.2BC X l(2)gl4 /CyO;+/+ 29 38 67 
+/+; arl14107/arl14107 X l(2)gl4 /CyO;+/+ 23 31 54 
+/+; FRT2A/FRT2A  X l(2)gl4 /CyO;+/+ 30 40 70 
+/+; arl19.2BC/arl19.2BC X ds38k /CyO;+/+ 26 34 60 
+/+; arl14107/arl14107 X ds38k /CyO;+/+ 24 28 52 
+/+; FRT2A/FRT2A  X ds38k /CyO;+/+ 26 28 54 
+/+; arl19.2BC/arl19.2BC X cadN2- /CyO;+/+ 43 31 74 
+/+; arl14107/arl14107 X cadN2- /CyO;+/+ 24 33 57 
+/+; FRT2A/FRT2A  X cadN2- /CyO;+/+ 22 22 44 
+/+; arl19.2BC/arl19.2BC X cadN- /CyO;+/+ 17 19 36 
+/+; arl14107/arl14107 X cadN- /CyO;+/+ 24 32 56 
+/+; FRT2A/FRT2A  X cadN- /CyO;+/+ 19 24 43 
+/+; arl19.2BC/arl19.2BC X cadNM12 /CyO;+/+ 44 31 75 
+/+; arl14107/arl14107 X cadNM12 /CyO;+/+ 34 28 62 
+/+; FRT2A/FRT2A  X cadNM12 /CyO;+/+ 30 25 55 
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TABLE III-9. Genetic interaction tests between arl1 alleles and mutations in adhesion 
genes on the 3rd chromosome (*Tm3: Balancer chromosome). 
Genetic cross #Tm3* #Non-Tm3  #Total 
+/+; arl19.2BC/arl19.2BC X +/+; cad74A-/Tm3 90 87 177 
+/+; arl14107/arl14107 X +/+; cad74A- /Tm3 106 97 203 
+/+; FRT2A/FRT2A  X +/+; cad74A-/Tm3 103 73 176 
+/+; arl19.2BC/arl19.2BC X +/+;fat2-/Tm3 62 53 115 
+/+; arl14107/arl14107 X  +/+;fat2-/Tm3 19 23 42 
+/+; FRT2A/FRT2A X  +/+;fat2-/Tm3 68 53 121 
+/+; arl19.2BC/arl19.2BC X +/+; scribj7B3 /Tm3 63 53 116 
+/+; arl14107/arl14107 X +/+; scribj7B3/Tm3 23 21 44 
+/+; FRT2A/FRT2A  X +/+; scribj7B3/Tm3 124 131 255 
 
 
 
 
 
 
TABLE III-10. Genetic interaction test between arl1 alleles and mutations in candidate 
genes (2nd chromosome), which may act redundantly with Arl1 (*Cyo: Balancer 
chromosome) . 
Genetic Cross #CyO*  #Non-CyO  #Total 
+/+; arl19.2BC/arl19.2BC X + /CyO;+/+ 371 444 815 
+/+; arl14107/arl14107 X +/CyO;+/+ 146 179 325 
+/+; FRT2A/FRT2A  X  +/CyO;+/+ 320 364 684 
+/+; arl19.2BC/arl19.2BC X rab6D23D/CyO;+/+ 111 128 239 
+/+; arl14107/arl14107 X rab6D23D/CyO;+/+ 57 61 118 
+/+; FRT2A/FRT2A  X rab6D23D/CyO;+/+ 34 35 69 
+/+; arl19.2BC/arl19.2BC X rab608323/CyO;+/+ 44 53 97 
+/+; arl14107/arl14107 X rab608323/CyO;+/+ 32 39 71 
+/+; FRT2A/FRT2A  X rab608323/CyO;+/+ 53 60 113 
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TABLE III-11. Genetic interaction test between arl1 alleles and mutations in candidate 
genes (3rd chromosome), which may act redundantly with Arl1 or or be involved in 
post-translational modification of redundant gene products (*Tm3: Balancer 
chromosome). 
Genetic cross #Tm3* #Non-Tm3  #Total 
+/+; arl19.2BC/arl19.2BC X +/+; arf79F-/Tm3 136 203 339 
+/+; arl14107/arl14107 X +/+; arf79F-/Tm3 51 74 125 
+/+; FRT2A/FRT2A  X +/+; arf79F-/Tm3 66 95 161 
+/+; arl19.2BC/arl19.2BC X +/+;rab1193bj/Tm3 154 225 379 
+/+; arl14107/arl14107 X  +/+; rab1193bj/Tm3 60 80 140 
+/+; FRT2A/FRT2A X  +/+; rab1193bj/Tm3 193 214 407 
+/+; arl19.2BC/arl19.2BC X +/+; rab11j2d/Tm3 119 179 298 
+/+; arl14107/arl14107 X +/+; rab11j2d/Tm3 65 93 158 
+/+; FRT2A/FRT2A  X +/+; rab11j2d/Tm3 132 198 330 
+/+; arl19.2BC/arl19.2BC X +/+; rabGGT-/Tm3 62 73 135 
+/+; arl14107/arl14107 X +/+; rabGGT-/Tm3 27 23 50 
+/+; FRT2A/FRT2A  X +/+; rabGGT-/Tm3 83 85 168 
 
 
 
 
 
 
TABLE III-12. Some egg chambers have border cell migration defects upon over-
expression of arl1Q70L-mCherry germ cells. 
 
Maternal # w/ Border Cell migration defects (%) #Normal (%) #Total 
Arl1-mCherry 0 (0) 32 (100) 32 
arl1Q70L-mCherry 4 (7.8) 47 (92.2) 51 
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TABLE III-13. Genetic interaction tests of mutations in adhesion genes or candidate 
genes, which may act redundantly with Arl1  (border cell migration assay). 
Alleles Normal gene products Genetics interaction with arl1
Q70L-mCherry ? 
Rab6D23D Rab6  No 
Rab608323 Rab6 No 
arf79F- Arf1 No 
rab1193bj Rab11 No 
rab11j2d Rab11 No 
rabGGT- Rab geranylgeranyl transferace No 
shg k03401 E-cadherin No 
shgR69 E-cadherin No 
dystroglycan
- Dystroglycan 
No 
dgB148 Dystroglycan No 
ftg-rv Protocadherin Fat No 
stan192 Atypic cadhein Flamingo No 
l(2)gl4 Giant Larva (cytoskeleton protein) No 
ds38k Dachsous (Cadherin) No 
cadN2- Neural Cadherin 2  No 
cadN- Neural Cadherin No 
cadNM12 Neural Cadherin No 
cad74A- Cadherin74A No 
fat2- Protocadherin Fat2 No 
scribj7B3 Septate junction Scribble No 
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Figure Legends 
FIGURE III-1. Molecular lesions of arl1 alleles: Schematic representations of Arl1 
proteins are shown. Wild type Arl1 (180 amino acids) consists of 6!-helices and 6'-stands 
(WU et al. 2003). The arl14107 mutation is predicted to encode a truncated Arl1 protein of 165 
amino acids, lacking the C-terminal 15 amino acids; this region is known to form an "-
helical ("5) structure in mammalian Arl1. The arl19.2BC mutation is likely a complete loss-of-
function allele, as it was predicted to encode a truncated Arl1 protein of 36 amino acids.  The 
equivalent change for mammalian Arl1 would eliminate the effector and all known protein 
interaction domains.    
FIGURE III-2. Head involution defects in embryos of arl1 mutants: (A-C) Embryos 
stained with anti-FasIII antibodies are shown at 40X magnification. (A) A wild type (WT) 
embryo with normal epithelial pattern. (B) An embryo derived from an arl19.2BC/arl19.2BC 
germ cell exhibits head involution defects (arrow). (C) An embryo derived from an 
arl14107/arl14107 germ cell exhibits an abnormal epithelial pattern (head involution defect and 
body hole are denoted by arrow and square, respectively). (D) An example of normal WT 
embryonic cuticle is shown. (E) An embryo cuticle derived from an arl19.2BC/arl19.2BC germ 
cell exhibits a head involution defect (arrow). (F) An embryo cuticle derived from an 
arl14107/arl14107germ cell with a head involution defect (arrow and large body hole (arrow 
head). (G) Square inset from (C) is shown at 100X magnification with arrow denoting body 
hole.  
    FIGURE III-3. A border cell migration defect in a stage 10 egg chamber expressing 
arl1Q70L-mCherry: Border cells are stained with anti-FasIII and denoted by arrows. (A) In a 
wild type egg chamber, border cells arrive at the anterior end of the oocyte at stage 10. (B) A 
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stage 10 egg chamber expressing Arl1-mCherry with normal border cell migration. (C) A 
stage 10 egg chamber expressing arl1Q70L-mCherry exhibits a border cell migration defect.  
        FIGURE III-4. Accumulation of Arl1 mRNA in embryos: Arl1 mRNA was 
ubiquitously distributed in embryos with a higher level in certain tissues. (A) A stage 5 
cellularized embryo with Arl1 mRNAs enriched within the cortical layer. (B-E) During 
stages 6-10, abundant Arl1 mRNAs were detected in the ventral (arrow v), cephalic (arrow c), 
anterior and posterior transverse (arrows at and pt, respectively) furrows. (F) A late staged 11 
embryo that has formed segmentation furrows shows a ubiquitous pattern of Arl1 mRNA 
accumulation.   (G-I) After the completion of gastrulation, Arl mRNAs show enriched 
accumulation in the brain lobes (arrows) and central nervous system (arrow head).  
        FIGURE III-5. Subcellular localization of Arl1 proteins in S2 cells: (A) In a S2 cell 
that is transfected with DNA encoding Arl1-EGFP (Green) and (A’) stained with Golgi 
marker TRITZ-Ceramide (red), (A’’) the EGFP-tagged Arl1 is colocalized with the Golgi 
marker. (B) When the N-terminal 1-17 region was removed ($17arl1-EGFP, green), Arl1 lost 
its fragmented punctate pattern and instead is dispersed throughout the cytoplasm. (C) In a 
S2 cell transfected with DNAs for Arl1-mCherry (red) and (C’) YFP-Golgi (Golgi marker, 
green), (C’’) mCherry-tagged Arl1 is colocalized with the Golgi marker. (D) Myc-tagged 
Arl1 (red) is colocalized with the YFP-Golgi (green) in S2 cells. 
        FIGURE III-6. Subcellular localization of Arl1 in oocyte and brain cells: In an 
oocyte expressing (A) Golgi marker YFP-Golgi (green) and (A’) Arl1-mCherry (red), (A’’) 
mCherry-tagged Arl1 proteins exhibit a nice colocalization with the Golgi marker. In brain 
cells expressing (B) Golgi marker YFP-Golgi (green) and (B’) Arl1-mCherry (red),   (B’’) 
the mCherry-tagged Arl1 is colocalized with the Golgi marker.   
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        FIGURE III-7. Arl1 can interact with the GRIP domain of Cbs in yeast two-hybrid 
assay: Interaction of Arl1 proteins, including wild type Arl1 and mutants expected to alter its 
preference for guanine nucleotide binding (arl1Q70L: GTP; arl1T30N: GDP), with the GRIP 
domain (GRIP) or the coiled-coil region (CC) preceding the GRIP domain was tested. Arl1 
binds to GRIP in a GTP dependent manner, but did not interact with the coiled-coil region 
preceding the GRIP domain.     
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FIGURE III-1 
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FIGURE III-2 
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FIGURE III-3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 93
FIGURE III-4 
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FIGURE III-5 
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FIGURE III-6 
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FIGURE III-7 
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CHAPTER 4. General Summary 
The Raf serine/threonine kinases play a key role in ERK signal transduction. However, 
the mechanisms of Raf regulation are complicated and remain elusive. Clues to regulatory 
events of Raf were derived from the identification of motifs/sites in these conserved regions. 
    Raf kinases consist of three conserved regions, CR1, CR2 and CR3. The catalytic kinase 
portion is located in the C-terminal CR3 region, while CR1 and CR2 represent the regulatory 
half of the Raf proteins. CR1 contains a Ras-binding domain (RBD) and a cysteine-rich 
domain (CRD), and is required for recruitment of Raf to the plasma membrane. The Ser/Thr-
rich region CR2 has a 14-3-3 binding site, but its functional role is less well defined 
(WELLBROCK et al. 2004). In addition to the three conserved regions, BRaf and DRaf 
contain an extended N-terminal segment. However, little attention was focused on this region 
thus far. 
 
Summary and Conclusions 
 With the general objective of understanding the roles of DRaf’s N-terminal segment 
and the CR2 region: 1) we analyzed the consequences of N-terminal deletion of DRaf both in 
vivo and in vitro, and found that the N-terminus of DRaf contains a novel conserved region 
and can contribute to Toros RTK signaling, potentially by assisting in Ras1 or Rap1 binding; 
2) we also performed a yeast two-hybrid screen using the CR2 region as the bait. We 
identified a small GTPase, Arl1, as a potential binding partner of CR2. Using genetics 
approaches we have made an effort to understand the functional roles of Arl1 in Drosophila. 
The studies in this dissertation are summarized here.    
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Drosophila Raf’s N-terminus Contains a Novel Conserved Region and Can 
Contribute to Torso RTK Signaling: To study the potential function of DRaf’s N-terminal 
residues (amino acids 1-114), we generated transgenic flies expressing full-length DRaf (FL 
DRaf) or DRaf proteins lacking amino-terminal residues 1-114 (DRaf$N114). At % endogenous 
wild type DRaf levels, maternally expressed DRaf$N114 was able to rescue the embryonic 
terminal defects of Draf11-29 mutants. However, when expressed at low maternal levels (~1/4 
endogenous wild type DRaf level), terminal defects, as well as, abnormal posterior tll 
expression pattern (<13% EL) was observed more often for embryos that inherited truncated 
DRaf$114 rather than full-length DRaf proteins. This finding suggested that deletion of the N-
terminual residues reduces DRaf’s signal potential in the Torso RTK pathway. Furthermore, 
in the sensitized torRL3 background, the ectopic gain-of-function effects of torRL3 allele were 
more significantly enhanced by over-expressed FL DRaf, compared to DRaf$114. Together, 
these data indicate that the extended N-terminal segment could contribute to Torso RTK 
signaling.  
Accordingly, FL DRaf also exhibited higher signal potential than DRaf$114 proteins in a 
trk1 background, in which a small amount of Torso signal activity may exist. Over-
expression of FL DRaf but not DRaf$114 partially restored the posterior terminal defects (A8 
denticle belt) in some embryos from trk1/trk1 mothers, again implying that the N-terminus 
can participate in Torso RTK signaling. However, in the torXR1/torXR1 background with 
complete loss of receptor activity, expression of neither FL DRaf nor DRaf restored terminal 
structures (A8 denticle belt). Thereby, the N-terminal region’s contribution to the RTK 
pathway appeared to be dependent on upstream receptor activity, suggesting that it may play 
a role(s) in transmission of the signal.      
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We analyzed the amino acid sequence of DRaf’s N-terminus and identified a novel 
region (CRN) conserved in BRaf proteins. Circular dichroism analysis indicated that DRaf’s 
N-terminus (amino acids 1-117) including CRN (amino acids 19-77) is folded in vitro and 
has a high content of helical secondary structure as predicted by proteomics tools. In yeast 
two-hybrid assays, stronger interactions between DRaf’s Ras binding domain (RBD) and the 
small GTPase Ras1, as well as Rap1, were observed when CRN and RBD sequences were 
linked. This is consistent with the results obtained by Fischer et al. (2007) for BRaf.  
Together, our in vivo and in vitro assays suggest that DRaf’s extended N-terminus can 
assist in its association with the upstream activators (Ras1 and Rap1) in vivo and thus, play a 
regulatory role(s) in DRaf signal transmission potentially through a CRN-mediated 
mechanism(s). 
The N-terminus of DRaf seems to participate in Ras1 and Rap1 binding, but as an 
isolated protein fragment cannot directly interact with Ras1 or Rap1. Furthermore, the effects 
of the N-terminal residues on Ras1 or Rap1 binding in vitro, as well as on Torso RTK 
signaling in vivo appears to be subtle. However, the minor contribution of the extended N-
terminus could have important biological implications. We propose that tight association 
with Ras1 or Rap1 through RBD and CRD regions is required and sufficient to initiate the 
activation of DRaf, while minor adjustments/regulation of the interaction by CRN could 
optimize signaling potential and reduce variability. Thus, the extended N-terminus including 
CRN may play a role(s) as one element in a multi-domain effort to promote DRaf’s 
interaction with Ras1 and Rap1, participating and assisting in its regulation to reliably attain 
maximal signal output.    
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Initial characterization of Drosophila Arl1: We initiated our study on Arl1 based on 
the hypothesis that Arl1 may be involved in DRaf signaling, since Arl1 can interact with the 
CR2 region of DRaf in our Yeast two-hybrid assay. Three different arl1 alleles were 
analyzed using classical genetic methods. However, we did not detect DRaf relevant 
phenotypes for Arl1 mutants.  
We found most homozygous arl1- mutants proceeded through embryogenesis and died 
during larval-pupa stage. Cuticles of unhatched embryos or arl1-/arl1- larvae appeared to be 
relatively normal. Thereby, zygotic Arl1 may not be essential for the development of 
embryos.      
Next we generated females with arl1-/arl1- germ cells to understand Arl1’s maternal 
role. Most embryos lacking maternal Arl1 activity appeared to be relatively normal, although 
~6% of them exhibited head involution defects. When crossed with arl1-/+ males, the 
hatching rates of eggs from females with arl1-/arl1- germ lines were not significantly altered, 
implying removal of paternal Arl1 in half of the eggs did not appear to affect their 
embryogenesis. It seems that both maternal and zygotic Arl1 is limitedly required during 
embryo development.  
The head involution defects we observed, although at low penetrance, suggest Arl1 can 
be involved in cellular morphogenesis. Considering Arl1’s potential role(s) in intracellular 
transport, we tested for genetic interaction between arl1 alleles and mutations in numerous 
genes encoding membrane-localized adhesion molecules. These have been shown or are 
thought to function in cellular morphogenetic movement due to their dynamic presence on 
the cell surface, which is regulated by endocytosis and exocytosis (EDELMAN 1985; 
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GUMBINER 1996; BRYANT and STOW 2004; VANHOOK and LETSOU 2007). However, no 
additive or synergistic effects were seen.        
The mild phenotypes observed in arl1 mutants could be due to the functional 
redundancy of Arl1 with other small GTPases, including Rab proteins. However no genetic 
interaction, with the limited number of candidates that we tested, was detected. Therefore, 
there might be other proteins that function redundantly with Arl1. Together, our analysis 
implies that it is difficult to dissect Arl1’s roles using classical genetic methods to study these 
arl1 alleles.     
Next, we employed an over-expression strategy to characterize Arl1’s function in 
Drosophila. We found over-expression of arl1Q70L-mCherry in germ cells reduced female 
fertility and ~8% of stage 10 egg chambers of these females exhibited delay in border cell 
migration. Considering Arl1’s potential functions in intracellular transport, we proposed that 
the border cell migration defects upon over-expression of arl1Q70L-mCherry might be due to 
dysregulation of the adhesion molecules in nurse cells. However, none of the mutations in 
adhesion molecules we tested showed additive or synergistic effects when arl1Q70L-mCherry 
was over-expressed in nurse cells.     
We also examined Drosophila Arl1's subcellular localization. Epitope-tagged Arl1 
proteins were colocalized with golgi markers both in vitro for Drosophila S2 cells and in vivo 
for the oocyte and brain cells. This is consistent with the studies by others in yeast and 
mammalian cells. We also found that the mRNA of Ar11 ubiquitously accumulates in 
embryos with higher levels observed for certain tissues.    
Together, our genetic analysis of three different arl1 alleles suggested that Arl1 could 
function in cell morphogenesis. Although Arl1 was found to interact with DRaf’s CR2 region 
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in our yeast two-hybrid assay, it seemed that mutations in Arl1 did not alter DRaf signaling. 
While an essential gene, Arl1 plays limited roles during Drosophila embryogenesis, likely 
due to the functional redundancy with other genes. Our studies provide the basis, which may 
be helpful for further characterization of Arl1’s function.     
 
Suggestions for Future Research 
Study of DRaf or BRaf’s N-terminus:  
1) The N-terminus of DRaf appears to participate in Ras1 binding, however, the details 
of this process is still unclear. Structural analysis of the complexes (i.e., NRBD-Ras etc.), 
may provide important clues and help to understand the molecular mechanism(s) by which 
CRN assists in Ras-Raf interaction.   
2) The CRN region contains several conserved putative phosphorylation sites, which 
may play regulatory roles in DRaf or BRaf signaling. Studying the consequences of point 
mutation on DRaf’s signal potential or Ras binding would provide important insights into the 
functional roles and mechanisms of this N-terminal region.      
3) Compared to ARaf and CRaf, BRaf is more liable to oncogenic mutation, likely due 
to its higher basal activity. The negative charged D447-D448 motif (corresponding to E420-
E421 in DRaf) preceding the kinase domain in BRaf mimics the constitutive phosphorylation 
in this region (MASON et al., 1999). This may account for its high basal activity. Fischer et al. 
(2007) reported that CRaf’s activity was elevated ~25% by the addition of the first 98 amino 
acids of BRaf to its N-terminus, implying that the extended N-terminus may contribute to 
BRaf’s high basal activity, too. One could test if there is additive or synergistic interaction 
between the N-terminal residues and the negative charged phophomimetic motif. Particularly, 
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comparing the activity of DRaf$N114,V420V421, DRafV420V421, DRaf$N114 and FL DRaf 
(BRaf$N98,V447V448, BRaf$N98,V447V448, BRaf$N98 and FL BRaf) would be helpful to extend our 
understanding of DRaf or BRaf’s basal activity, as well as, the liability to oncogenic 
mutations. 
4) BRafV599E accounts for ~90% oncogenic BRaf mutations in human cancers (SRIKALA 
et al. 2005). BRafV599E is a constitutive active mutant. Although its gain-of-function effects 
seem independent of Ras binding, it is still possible that presence of the extended N-terminus 
may contribute to its constitutive activity. One could test if the deletion of the N-terminus 
affects the oncogenic activity of BRafV599E.  
 
Further characterization on Arl1: 
1) While an essential gene, Arl1 seems to play limited roles in Drosophila 
embryogenesis. Only mild defects were observed in Arl1 mutants. Lack of significant 
phenotypic information is likely due to its functional redundancy with other genes. We tested 
whether there were additive or synergistic effects between arl1 alleles and mutations of 
several candidate genes, which may act redundantly with Arl1. However, due to the difficulty 
of generating complex genetic backgrounds using classical methods, we did not resolve the 
issue of functional redundancy because our genetics interaction assays appeared not sensitive 
enough. NIH has just begun to support a TRiP (Transgenic RNAi Project) project to develop 
the UAS-RNAi system in a genome-wide scale. One could also combine RNAi sequences of 
several different genes (Arl1, Rab2, Rab6, etc.) and simultaneously deplete their functions in 
flies. This would be very helpful for characterization of Arl1’s functions. 
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2) Identification of the components/cargo of Arl1 complex/trafficking machinery using 
proteomic approaches could also be helpful to characterize its developmental roles. 
Particularly, one could co-precipitate or pull-down the proteins of Arl1 complex from 
cellular lysates, and using mass spectrum analysis to identify the components. A combination 
of these proteomics approaches could allow the in vivo genetic analysis of Arl1 more 
promising.        
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APPENDIX 
 
Appendix 1. Genetic Screen for arl alleles: EMS mutagenesis 
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Appendix 2. List of primers 
 
Primer Sequence 
EcoRIRaf-F CGGAATTCACCATGTCCAGCGAGTCCTCCAC 
EcoRICR1-F CGGAATTCACCATGCACCACGGCAACGATC 
EcoRICR2-F CG GAA TTC ATG CTG TGC CAG CCC TTT C 
EcoRICR3-F CG GAA TTC GTG TGC ATC AAC AAC ATT CG 
EcoRI$17Raf-F CGGAATTCATGGCCGAGGAGCTGCAC 
EcoRI$77Raf-F CGGAATTCATGAACTCGCAGGACCAGC 
BamHIRaf-R CGCGGATCCCGCTGTTTAGATATTCCCAG 
BamHICR1-R CG GGATCC GAAAGGGC TA GCACAGCATC 
BamHIRBD-R CGG GAT CCT TAT TCC AGC AGC CTG ACA AAG ATC 
BamHICR2-R CG GGATCC GTT GTT GAT TCA CACATTTGG 
BamHIN-R CGGGATCCTCAATGTACTCGCGCCAATTGCCGTTG 
C110-F GGC CCT GAA ACT CCT GCA ACT AAC GCC GGA TAT G 
C110-R CAT ATC CGG CGT TAG TTG CAG GAG TTT CAG GGC C 
NTE-F GAATACCAGGAGTTGGAATCCAAGCTCCACGAACTG  
NTE-R CAGTTCGTGGAGCTTGGATTCCAACTCCTGGTATTC 
NTV-F GAA TAC CAG GAG TTG GTA TCC AAG CTC CAC GAA CTG 
NTV-R CAG TTC GTG GAG CTT GGA TAC CAA CTC CTG GTA TTC 
EcoRIRas-F CG GAA TTCATGACGGAATACAAACTGGTC 
BamHIRas$-R CG GGA TCC TA TCTACAATTCGGCTTGTTC 
EcoRIRap-F CGG AAT TCA TGC GTG AGT ACA AAA TCG TG 
BamHIRap$-R CGG GAT CCT TAT AGG GAC TTT TTC GGC TTC 
EcoRI1433-F CGGAATTCATGGCGACAGTCGATAAGG 
BamHI1433-R CG GGA TCC TAAGTTGTTTTGGTTAGTTGTC 
ClaIKSRCA-F CC AT CGA TCC AGGATGAGCAGCAACAAC 
XhoIKSRCA-R CCCTCGAG CTCTTATAGCCGCATCTTCG 
XhoIKSRCC-R CC CTC GAG TTA CGC AGT ACCGCTCTCCAG 
XhoIKSRN-R CC CTC GAG TCA GCC ACT GCT CGT CAC 
HindIIIArl-F AAGCTTCGCTCAACTTTGGCAGATAC 
HindIII$17arl-F CG AAGCTTA CCA TGC GCA TCT TAA TCC TGG 
BamHIArl-R CG GGATCC GA AAG TAT CTA CTT GCG ACT C 
KpnIArl-F GGGGTACCACACGCTCAACTTTGGCAGATAC 
XbaIArl-R GC TCT AGA TGA TGA CTT CCG ACT CTG C 
XbaImChe-F GATCTAGAGCAACCATGGTGAGCAAGG 
AgeImChe-R TCACCGGTTTCTTACTTGTACAGCTCGTC 
EcoRIArl-F CG GAA TTC ACC ATG GGT GGG GTG CTC 
BamHIChe-R CG GGA TCC TTCTTACTTGTACAGCTCGTC 
EcoRI$17arl-F CGG AAT TCA CCA TGC GCA TCT TAA TCC TGG 
BamHIArlS-R CG GGATCC GA AAG TAT CTA CTT GCG ACT C 
T30N-F GA CGG CGC CGG CAA GAA CAC GAT CCT CTA CAG 
T30N-R CTG TAG AGG ATC GTG TTC TTG CCG GCG CCG TC 
NdeICbsCC-F CC CAT ATG GACGAAACCATAATGCAACTG 
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BamHICbsCC-R CG GGA TCC GTGTTTCAAATATTGAAAATTAAC 
EcoRIGrip-F CG GAA TTC GTTAATTTTCAATATTTGAAACAC 
BamHIGrip-R CG GG ATC CTA CAA TGT GTC GTG TAG CAG C 
tll-F TCGGAGGGTTCACCAGAC 
tll-R GAGATGAGGCGCACAATGG 
en-F AATGGCCCTGGAGGATCG 
en-R CCGTCAGAAGGAGTAACCC 
P1-F GCGCCA GCACTAGACAAAG 
P1-R GAAATAGCACGAATTGAGATTAG 
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